{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "from pathlib import Path\n",
    "\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "from rdkit.Chem import PandasTools"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "FILE_LOCATION = Path(\"../data/MalariaData_bioactivity.txt\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/mr/bl2q5rxs0t3d8d8tn7wdcxz80000gp/T/ipykernel_96627/2337347344.py:1: DtypeWarning: Columns (30) have mixed types. Specify dtype option on import or set low_memory=False.\n",
      "  df = pd.read_table(FILE_LOCATION)\n"
     ]
    }
   ],
   "source": [
    "df = pd.read_table(FILE_LOCATION)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>MOLREGNO</th>\n",
       "      <th>MOL_CHEMBL_ID</th>\n",
       "      <th>DOWNGRADED</th>\n",
       "      <th>CANONICAL_SMILES</th>\n",
       "      <th>STANDARD_INCHI</th>\n",
       "      <th>FULL_MWT</th>\n",
       "      <th>ALOGP</th>\n",
       "      <th>ACD_LOGP</th>\n",
       "      <th>ACD_LOGD</th>\n",
       "      <th>PSA</th>\n",
       "      <th>...</th>\n",
       "      <th>TARGET_TYPE</th>\n",
       "      <th>PREF_NAME</th>\n",
       "      <th>ORGANISM</th>\n",
       "      <th>TARGET_CHEMBL_ID</th>\n",
       "      <th>JOURNAL</th>\n",
       "      <th>YEAR</th>\n",
       "      <th>TITLE</th>\n",
       "      <th>PUBMED_ID</th>\n",
       "      <th>DOI</th>\n",
       "      <th>DOC_TYPE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>23</td>\n",
       "      <td>CHEMBL6206</td>\n",
       "      <td>0</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...</td>\n",
       "      <td>317.18</td>\n",
       "      <td>3.52</td>\n",
       "      <td>4.39</td>\n",
       "      <td>4.39</td>\n",
       "      <td>26.3</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PubChem BioAssay data set</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DATASET</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>23</td>\n",
       "      <td>CHEMBL6206</td>\n",
       "      <td>0</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...</td>\n",
       "      <td>317.18</td>\n",
       "      <td>3.52</td>\n",
       "      <td>4.39</td>\n",
       "      <td>4.39</td>\n",
       "      <td>26.3</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PubChem BioAssay data set</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DATASET</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>23</td>\n",
       "      <td>CHEMBL6206</td>\n",
       "      <td>0</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...</td>\n",
       "      <td>317.18</td>\n",
       "      <td>3.52</td>\n",
       "      <td>4.39</td>\n",
       "      <td>4.39</td>\n",
       "      <td>26.3</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PubChem BioAssay data set</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DATASET</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>23</td>\n",
       "      <td>CHEMBL6206</td>\n",
       "      <td>0</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...</td>\n",
       "      <td>317.18</td>\n",
       "      <td>3.52</td>\n",
       "      <td>4.39</td>\n",
       "      <td>4.39</td>\n",
       "      <td>26.3</td>\n",
       "      <td>...</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHEMBL612545</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PubChem BioAssay data set</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DATASET</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>111</td>\n",
       "      <td>CHEMBL266459</td>\n",
       "      <td>0</td>\n",
       "      <td>[Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2</td>\n",
       "      <td>InChI=1S/C15H14ClNO3.Na/c1-9-7-12(8-13(18)19)1...</td>\n",
       "      <td>313.71</td>\n",
       "      <td>3.93</td>\n",
       "      <td>3.36</td>\n",
       "      <td>0.27</td>\n",
       "      <td>59.3</td>\n",
       "      <td>...</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>CHEMBL364</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PubChem BioAssay data set</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>DATASET</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 44 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   MOLREGNO MOL_CHEMBL_ID  DOWNGRADED  \\\n",
       "0        23    CHEMBL6206           0   \n",
       "1        23    CHEMBL6206           0   \n",
       "2        23    CHEMBL6206           0   \n",
       "3        23    CHEMBL6206           0   \n",
       "4       111  CHEMBL266459           0   \n",
       "\n",
       "                                 CANONICAL_SMILES  \\\n",
       "0             Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "1             Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "2             Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "3             Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "4  [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2   \n",
       "\n",
       "                                      STANDARD_INCHI  FULL_MWT  ALOGP  \\\n",
       "0  InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...    317.18   3.52   \n",
       "1  InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...    317.18   3.52   \n",
       "2  InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...    317.18   3.52   \n",
       "3  InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-...    317.18   3.52   \n",
       "4  InChI=1S/C15H14ClNO3.Na/c1-9-7-12(8-13(18)19)1...    313.71   3.93   \n",
       "\n",
       "   ACD_LOGP  ACD_LOGD   PSA  ... TARGET_TYPE              PREF_NAME  \\\n",
       "0      4.39      4.39  26.3  ...   UNCHECKED              Unchecked   \n",
       "1      4.39      4.39  26.3  ...   UNCHECKED              Unchecked   \n",
       "2      4.39      4.39  26.3  ...   UNCHECKED              Unchecked   \n",
       "3      4.39      4.39  26.3  ...   UNCHECKED              Unchecked   \n",
       "4      3.36      0.27  59.3  ...    ORGANISM  Plasmodium falciparum   \n",
       "\n",
       "                ORGANISM TARGET_CHEMBL_ID  JOURNAL YEAR  \\\n",
       "0                    NaN     CHEMBL612545      NaN  NaN   \n",
       "1                    NaN     CHEMBL612545      NaN  NaN   \n",
       "2                    NaN     CHEMBL612545      NaN  NaN   \n",
       "3                    NaN     CHEMBL612545      NaN  NaN   \n",
       "4  Plasmodium falciparum        CHEMBL364      NaN  NaN   \n",
       "\n",
       "                       TITLE  PUBMED_ID  DOI  DOC_TYPE  \n",
       "0  PubChem BioAssay data set        NaN  NaN   DATASET  \n",
       "1  PubChem BioAssay data set        NaN  NaN   DATASET  \n",
       "2  PubChem BioAssay data set        NaN  NaN   DATASET  \n",
       "3  PubChem BioAssay data set        NaN  NaN   DATASET  \n",
       "4  PubChem BioAssay data set        NaN  NaN   DATASET  \n",
       "\n",
       "[5 rows x 44 columns]"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(532413, 44)"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0         False\n",
       "1         False\n",
       "2         False\n",
       "3         False\n",
       "4         False\n",
       "          ...  \n",
       "532408    False\n",
       "532409    False\n",
       "532410    False\n",
       "532411    False\n",
       "532412    False\n",
       "Length: 532413, dtype: bool"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.duplicated()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "df = df.drop_duplicates()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(532413, 44)"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['MOLREGNO', 'MOL_CHEMBL_ID', 'DOWNGRADED', 'CANONICAL_SMILES',\n",
       "       'STANDARD_INCHI', 'FULL_MWT', 'ALOGP', 'ACD_LOGP', 'ACD_LOGD', 'PSA',\n",
       "       'SRC_DESCRIPTION', 'ASSAY_DESCRIPTION', 'ASSAY_CATEGORY',\n",
       "       'ASSAY_ORGANISM', 'ASSAY_TAX_ID', 'ASSAY_STRAIN', 'ASSAY_CHEMBL_ID',\n",
       "       'ACTIVITY_ID', 'ASSAY_ID', 'DOC_ID', 'RECORD_ID', 'STANDARD_RELATION',\n",
       "       'PUBLISHED_VALUE', 'PUBLISHED_UNITS', 'STANDARD_VALUE',\n",
       "       'STANDARD_UNITS', 'STANDARD_FLAG', 'STANDARD_TYPE', 'ACTIVITY_COMMENT',\n",
       "       'PUBLISHED_TYPE', 'DATA_VALIDITY_COMMENT', 'POTENTIAL_DUPLICATE',\n",
       "       'PUBLISHED_RELATION', 'PCHEMBL_VALUE', 'TARGET_TYPE', 'PREF_NAME',\n",
       "       'ORGANISM', 'TARGET_CHEMBL_ID', 'JOURNAL', 'YEAR', 'TITLE', 'PUBMED_ID',\n",
       "       'DOI', 'DOC_TYPE'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ASSAY_CATEGORY\n",
       "confirmatory    320502\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.ASSAY_CATEGORY.value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "new_df = df[['MOLREGNO', 'CANONICAL_SMILES', 'ASSAY_DESCRIPTION', 'ASSAY_CATEGORY',\n",
    "            'ASSAY_ORGANISM', 'STANDARD_VALUE', 'STANDARD_UNITS', 'PCHEMBL_VALUE', \n",
    "            'TARGET_TYPE', 'PREF_NAME', 'ORGANISM',]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>MOLREGNO</th>\n",
       "      <th>CANONICAL_SMILES</th>\n",
       "      <th>ASSAY_DESCRIPTION</th>\n",
       "      <th>ASSAY_CATEGORY</th>\n",
       "      <th>ASSAY_ORGANISM</th>\n",
       "      <th>STANDARD_VALUE</th>\n",
       "      <th>STANDARD_UNITS</th>\n",
       "      <th>PCHEMBL_VALUE</th>\n",
       "      <th>TARGET_TYPE</th>\n",
       "      <th>PREF_NAME</th>\n",
       "      <th>ORGANISM</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>23</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>PUBCHEM_BIOASSAY: qHTS for differential inhibi...</td>\n",
       "      <td>confirmatory</td>\n",
       "      <td>NaN</td>\n",
       "      <td>19952.60</td>\n",
       "      <td>nM</td>\n",
       "      <td>4.70</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>23</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>PUBCHEM_BIOASSAY: qHTS for differential inhibi...</td>\n",
       "      <td>confirmatory</td>\n",
       "      <td>NaN</td>\n",
       "      <td>11220.20</td>\n",
       "      <td>nM</td>\n",
       "      <td>4.95</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>23</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>PUBCHEM_BIOASSAY: qHTS for differential inhibi...</td>\n",
       "      <td>confirmatory</td>\n",
       "      <td>NaN</td>\n",
       "      <td>12589.30</td>\n",
       "      <td>nM</td>\n",
       "      <td>4.90</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>23</td>\n",
       "      <td>Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23</td>\n",
       "      <td>PUBCHEM_BIOASSAY: qHTS for differential inhibi...</td>\n",
       "      <td>confirmatory</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10000.00</td>\n",
       "      <td>nM</td>\n",
       "      <td>5.00</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>111</td>\n",
       "      <td>[Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2</td>\n",
       "      <td>PUBCHEM_BIOASSAY: Primary qHTS for delayed dea...</td>\n",
       "      <td>confirmatory</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>13115.40</td>\n",
       "      <td>nM</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532408</th>\n",
       "      <td>1540450</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>Growth inhibition after 72 hrs of Plasmodium f...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>22.20</td>\n",
       "      <td>nM</td>\n",
       "      <td>7.65</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532409</th>\n",
       "      <td>1540450</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>GSK_TCMDC: Inhibition of Plasmodium falciparum...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>0.00</td>\n",
       "      <td>%</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532410</th>\n",
       "      <td>1540450</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>GSK_TCMDC: Inhibition of Plasmodium falciparum...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>100.00</td>\n",
       "      <td>%</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532411</th>\n",
       "      <td>1540450</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>GSK_TCMDC: Inhibition Frequency Index (IFI). T...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.71</td>\n",
       "      <td>%</td>\n",
       "      <td>NaN</td>\n",
       "      <td>UNCHECKED</td>\n",
       "      <td>Unchecked</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>532412</th>\n",
       "      <td>1540450</td>\n",
       "      <td>Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...</td>\n",
       "      <td>Growth inhibition after 72 hrs of Plasmodium f...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>6.60</td>\n",
       "      <td>nM</td>\n",
       "      <td>8.18</td>\n",
       "      <td>ORGANISM</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "      <td>Plasmodium falciparum</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>532413 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        MOLREGNO                                   CANONICAL_SMILES  \\\n",
       "0             23                Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "1             23                Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "2             23                Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "3             23                Br\\C=C\\1/CCC(C(=O)O1)c2cccc3ccccc23   \n",
       "4            111     [Na+].Cc1cc(CC(=O)[O-])n(C)c1C(=O)c2ccc(Cl)cc2   \n",
       "...          ...                                                ...   \n",
       "532408   1540450  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "532409   1540450  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "532410   1540450  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "532411   1540450  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "532412   1540450  Cl.COc1ccc2nccc([C@@H](O)[C@@H]3CC4CCN3C[C@@H]...   \n",
       "\n",
       "                                        ASSAY_DESCRIPTION ASSAY_CATEGORY  \\\n",
       "0       PUBCHEM_BIOASSAY: qHTS for differential inhibi...   confirmatory   \n",
       "1       PUBCHEM_BIOASSAY: qHTS for differential inhibi...   confirmatory   \n",
       "2       PUBCHEM_BIOASSAY: qHTS for differential inhibi...   confirmatory   \n",
       "3       PUBCHEM_BIOASSAY: qHTS for differential inhibi...   confirmatory   \n",
       "4       PUBCHEM_BIOASSAY: Primary qHTS for delayed dea...   confirmatory   \n",
       "...                                                   ...            ...   \n",
       "532408  Growth inhibition after 72 hrs of Plasmodium f...            NaN   \n",
       "532409  GSK_TCMDC: Inhibition of Plasmodium falciparum...            NaN   \n",
       "532410  GSK_TCMDC: Inhibition of Plasmodium falciparum...            NaN   \n",
       "532411  GSK_TCMDC: Inhibition Frequency Index (IFI). T...            NaN   \n",
       "532412  Growth inhibition after 72 hrs of Plasmodium f...            NaN   \n",
       "\n",
       "               ASSAY_ORGANISM  STANDARD_VALUE STANDARD_UNITS  PCHEMBL_VALUE  \\\n",
       "0                         NaN        19952.60             nM           4.70   \n",
       "1                         NaN        11220.20             nM           4.95   \n",
       "2                         NaN        12589.30             nM           4.90   \n",
       "3                         NaN        10000.00             nM           5.00   \n",
       "4       Plasmodium falciparum        13115.40             nM            NaN   \n",
       "...                       ...             ...            ...            ...   \n",
       "532408  Plasmodium falciparum           22.20             nM           7.65   \n",
       "532409  Plasmodium falciparum            0.00              %            NaN   \n",
       "532410  Plasmodium falciparum          100.00              %            NaN   \n",
       "532411                    NaN            0.71              %            NaN   \n",
       "532412  Plasmodium falciparum            6.60             nM           8.18   \n",
       "\n",
       "       TARGET_TYPE              PREF_NAME               ORGANISM  \n",
       "0        UNCHECKED              Unchecked                    NaN  \n",
       "1        UNCHECKED              Unchecked                    NaN  \n",
       "2        UNCHECKED              Unchecked                    NaN  \n",
       "3        UNCHECKED              Unchecked                    NaN  \n",
       "4         ORGANISM  Plasmodium falciparum  Plasmodium falciparum  \n",
       "...            ...                    ...                    ...  \n",
       "532408    ORGANISM  Plasmodium falciparum  Plasmodium falciparum  \n",
       "532409    ORGANISM  Plasmodium falciparum  Plasmodium falciparum  \n",
       "532410    ORGANISM  Plasmodium falciparum  Plasmodium falciparum  \n",
       "532411   UNCHECKED              Unchecked                    NaN  \n",
       "532412    ORGANISM  Plasmodium falciparum  Plasmodium falciparum  \n",
       "\n",
       "[532413 rows x 11 columns]"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "new_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       " 'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 7D3), 1828 (Summary assay)]',\n",
       " 'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8. (Class of assay: confirmatory) ',\n",
       " 'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4. (Class of assay: confirmatory) ',\n",
       " 'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]',\n",
       " 'PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]',\n",
       " 'Binding affinity to Plasmodium falciparum spermidine synthase by saturation transfer difference-NMR experiment',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay',\n",
       " 'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1876 (Assay for Plasmodium falciparum line 3D7), 1828 (Summary assay)]',\n",
       " 'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10. (Class of assay: confirmatory) [Related PubChem assays: 1815 (Assay for Plasmodium falciparum line 7G8), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay',\n",
       " 'Inhibition of Plasmodium falciparum thioredoxin reductase by DTNB assay',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of chloroquine',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of mefloquine',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of artemether',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of quinine',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 50 mg/kg/day, ip measured on day 4 postinfection',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of pyrimethamine',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum Dd2',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of methylene blue',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of chloroquine',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 1 mg/kg/day, po measured on day 4 postinfection',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum W2',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as recrudescence of malaria at 50 mg/kg/day, ip measured upto day 60 postinfection',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as recrudescence of malaria at 100 mg/kg/day, ip measured upto day 60 postinfection',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as recrudescence of malaria at 5 mg/kg/day, ip measured upto day 60 postinfection',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of mefloquine',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum FcB1',\n",
       " 'Inhibition of Plasmodium falciparum glutathione S-transferase',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of artesunate',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 100 mg/kg/day, po measured on day 5 postinfection',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 50 mg/kg/day, po measured on day 4 postinfection',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of premaquine',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of atovaquone',\n",
       " 'Inhibition of Plasmodium falciparum glutathione reductase by spectrophotometer',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum FcM29',\n",
       " 'Antiplasmodial activity after 24 hrs against chloroquine-resistant, mefloquine-sensitive Plasmodium falciparum W2 infected human erythrocytes by [G-3H]hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of artemisinin',\n",
       " 'PUBCHEM_BIOASSAY: Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP). (Class of assay: confirmatory) ',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum FcM29 assessed as inhibition of parasite growth at 180 nM in presence of 0.87 uM N-acetyl-L-cysteine',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as mortality at 100 mg/kg, po treated 4 days after infection measured on day 7 postinfection',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum F32',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of artemisinin',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 in presence of amodiaquine',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 in presence of artesunate',\n",
       " 'Antiplasmodial activity against mefloquine-susceptible Plasmodium falciparum Dd2 assessed as 50% reversant concentration required for mefloquine resistant',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as inhibition of parasite growth at 100 mg/kg/day, ip measured on day 5 postinfection',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as survival at 10 mg/kg, ip treated 4 days before infection measured on day 6 postinfection',\n",
       " 'Antiplasmodial activity after 24 hrs against chloroquine-sensitive, mefloquine-resistant Plasmodium falciparum D6 infected human erythrocytes by [G-3H]hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       " 'Inhibition of Plasmodium falciparum thioredoxin reductase TrxR assay',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in Swiss mouse assessed as survival at 10 mg/kg, ip treated 4 days before infection measured on day 9 postinfection',\n",
       " 'Antimicrobial activity against Plasmodium falciparum',\n",
       " 'GSK_TCMDC: Percent inhibition of human HepG2 cell line. Test compounds present at 10uM.',\n",
       " 'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 LDH activity, using an LDH reporter assay. Test compounds present at 2uM',\n",
       " 'NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay ',\n",
       " 'GSK_TCMDC: Inhibition Frequency Index (IFI). The number of non-kinase HTS assays where a compound showed > 50 % inhibition, expressed as a percentage of the number of such assays in which the compound was tested',\n",
       " 'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       " 'NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)',\n",
       " 'NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.',\n",
       " 'NOVARTIS: Antimalarial liver stage activity measured as a greater than 50% reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells at 10uM compound concentration, determined by immuno-fluorescence.',\n",
       " 'GSK_TCMDC: Inhibition of Plasmodium falciparum Dd2 in whole red blood cells, using parasite LDH activity as an index of growth. Test compounds present at 2uM',\n",
       " 'GSK_TCMDC: Inhibition of Plasmodium falciparum 3D7 in whole erythrocytes, using parasite LDH activity as an index of growth.',\n",
       " 'NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 0-24 hrs post infection',\n",
       " 'Therapeutic index, ratio of IC50 for concanavalin-stimulated BALB/c mice (Mus musculus) splenocytes to IC50 for Plasmodium falciparum 3D7',\n",
       " 'Therapeutic index, ratio of IC50 for concanavalin-stimulated BALB/c mice (Mus musculus) splenocytes to IC50 for Plasmodium falciparum W2 after 48 hrs',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMT K2 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 0-12 hrs post infection',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMTVo1 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Not Plasmodium species',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 36-48 hrs post infection',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum PA infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity as 3rd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs dose then 48 hrs drug-free',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity as schizont arrest after 48 hrs in chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes at 6 uM 96 hrs post invasion by Giemsa staining',\n",
       " 'Antimalarial activity as segregation of apicoplasts against chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 schizont infected human erythrocytes at 6 uM 96 hrs post infection',\n",
       " 'Antimalarial activity as segregation of apicoplasts against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes at 6 uM 96 hrs post infection',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMTL1 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes after 96 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 12-36 hrs post infection',\n",
       " 'Antimalarial activity as parasitaemia against chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum IMT10500 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity as abnormal apicoplast morphology in chloroquine-sensitive ACP1-GFP-labeled Plasmodium falciparum 3D7 trophozoite infected human erythrocytes at 2xIC50 dosed 96 hrs post infection',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in erythrocytes after 96 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum W2',\n",
       " 'Antimalarial activity as 2nd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs by flow cytometry',\n",
       " 'In vitro antibacterial activity against gram negative P. aeruginosa DPHP 5263',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 12-24 hrs post infection',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 0-36 hrs post infection',\n",
       " 'Antimalarial activity as 3rd generation after 96 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes at 6 uM 0-48 hrs post invasion',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCR3 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCM29 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 12-48 hrs post infection',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 24-36 hrs post infection',\n",
       " 'Antimalarial activity as 3rd generation parasitaemia against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 96hrs at 6 uM dosed 24-48 hrs post infection',\n",
       " 'Antimalarial activity as 3rd generation ring-stage chloroquine-sensitive Plasmodium falciparum 3D7 after 48 hrs dose then 48 hrs drug-free',\n",
       " 'Antimalarial activity as 2nd generation ring-stage chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by flow cytometry',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Binding constant for PFPK5(P.falciparum) kinase domain',\n",
       " 'Binding constant for PFCDPK1(P.falciparum) kinase domain',\n",
       " 'Displacement of bis-ANS from Plasmodium falciparum 3D7 Hsp90 expressed in Escherichia coli BL21(DE3) assessed as reduction in fluorescence at 100 uM after 30 min by fluorescent monochromator spectrophotometry',\n",
       " 'Relative activity against FM3A cells and Plasmodium falciparum FCR3',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum FCR3',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       " 'Inhibition of Plasmodium falciparum recombinant GSK3 expressed in Escherichia coli using YRRAAVPPSPSLSRHSSPHQ-phosphoS-EDEEE as substrate and [gamma33P]ATP after 30 mins by scintillation counting',\n",
       " 'Antimalarial activity against multidrug-resistant Plasmodium falciparum isolate 208432 infected in human erythrocytes after 48 hrs by flow-cytometry',\n",
       " 'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488774]',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay',\n",
       " 'PUBCHEM_BIOASSAY: Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774]',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay',\n",
       " 'PUBCHEM_BIOASSAY: qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2. (Class of assay: confirmatory) [Related PubChem assays: 1876 (Assay for Plasmodium falciparum line 7D3), 1815 (Assay for Plasmodium falciparum line 7G8), 1877 (Assay for Plasmodium falciparum line D10), 1816 (Assay for Plasmodium falciparum line GB4), 1828 (Summary assay)]',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay',\n",
       " 'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 80 mg/kg subcutaneous dose ; 5 cured at 60 days post infection',\n",
       " 'Antimalarial activity as survivor number at day 60 against drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg subcutaneous dose after 72 hr',\n",
       " 'Antimalarial activity against Plasmodium berghei strain in mice (Mus musculus) by parentral route and change in mean survival time in days was determined at 160 mg/kg subcutaneous dose ; 5 cured at 60 days postinfection',\n",
       " 'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 320 mg/kg subcutaneous dose over 72 hrs',\n",
       " 'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 320 mg/kg subcutaneous dose ; 5 cured at 60 days post infection',\n",
       " 'Antimalarial activity as survivor numbers at day 60 against drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 20 mg/kg subcutaneous dose after 72 hr',\n",
       " 'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 40 mg/kg subcutaneous dose ; 5 cured at 60 days post infection',\n",
       " 'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) after 72 hr',\n",
       " 'Antimalarial activity against Plasmodium berghei strain in mice (Mus musculus) by parentral route and change in mean survival time in days was determined at 640 mg/kg subcutaneous dose ; 5 cured at 60 days postinfection',\n",
       " 'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 80 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Selectivity ratio of growth inhibition against Plasmodium falciparum TM4/8.2(wild-type) and T9/94(mutant)',\n",
       " 'Evaluated for activity of relative to Cycloguanil',\n",
       " 'Evaluated for inhibition constant (Ki wt) against Wild-type dihydrofolate reductase of Plasmodium falciparum',\n",
       " 'Inhibition of Plasmodium falciparum T9/94 mutant',\n",
       " 'Inhibition constant against Plasmodium falciparum dihydrofolate reductase',\n",
       " 'Evaluated for activity of compound relative to Cycloguanil',\n",
       " 'Ratio of inhibitory constant of mutant by wild-type DHFRs of Plasmodium falciparum',\n",
       " 'Inhibition constant (Ki mut) against A16V+S108T Mutant DHFRs of Plasmodium falciparum',\n",
       " 'Growth inhibition (IC50) against Plasmodium falciparum wild-type TM4/8.2',\n",
       " 'Antimalarial activity against Plasmodium berghei infected mice (Mus musculus) at 2.5 to 25 mg/kg',\n",
       " 'Inhibition of Plasmodium falciparum recombinant carbonic anhydrase',\n",
       " 'Ex vivo inhibition of Plasmodium falciparum growth in cultured cells after 48hrs as [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against Plasmodium falciparum isolate Kil-164 expressing DHFR Ser108Asn, Asn51Ile, Cys59Arg and Ile164Leu quadruple mutant by [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibitory activity against double mutant dihydrofolate reductase (C59R S108N DHFR), relative to trimethoprim',\n",
       " 'Inhibitory activity against wild-type dihydrofolate reductase (S108N DHFR), relative to trimethoprim',\n",
       " 'Inhibitory activity against wild-type dihydrofolate reductase (S108N DHFR)',\n",
       " 'Inhibitory activity against triple mutant dihydrofolate reductase (C59R S108 NI164L DHFR)',\n",
       " 'Antiplasmodial activity IC50 against Plasmodium falciparum K1CB1 DHFR double-mutant (C59R/S10)',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum NF10 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum KC2 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum D2 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum DAN after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum WE2 after 72 hrs by SYBR green assay',\n",
       " 'Inhibitory activity against double mutant dihydrofolate reductase (C59R+S108N DHFR)',\n",
       " 'Inhibition of Plasmodium falciparum DHFR',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum KH7 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum LC12 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum XE7 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JC9 after 72 hrs by SYBR green assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum Kenyan isolates by [3H]hypoxanthine incorporation assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum XG10 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JF11 after 72 hrs by SYBR green assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn, Asn51Ile and Cys59Arg triple mutant by [3H]hypoxanthine incorporation assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JF6 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JB12 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against transgenic Plasmodium falciparum Dd2 pDT harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum D10 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum V1S expressing DHFR quadruple mutant with point mutations at codons 108, 51, 59 and 164 gene by [3H]hypoxanthine incorporation assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum HB3 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum GB4 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JC3 after 72 hrs by SYBR green assay',\n",
       " 'Inhibitory activity against Dihydrofolate reductase enzyme purified from Plasmodium berghei.',\n",
       " 'IC50 ratio against Plasmodium falciparum K1CB1/TM4',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JB8 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum LA10 after 72 hrs by SYBR green assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum Kenyan isolates expressing DHFR Ser108Asn and Cys59Arg or Ser108Asn and Asn51Ile double mutant by [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibition of the wild-type dihydrofolate reductase (DHFR)',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum XB3 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum TF1 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against transgenic Plasmodium falciparum HB3 pDT harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum XF12 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum QF5 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JH6 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 3D7 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum WF12 after 72 hrs by SYBR green assay',\n",
       " 'In vitro inhibition of dihydrofolate reductase of Plasmodium berghei',\n",
       " 'Safety ratio as cytotoxicity in vero cells relative to IC50 TM4',\n",
       " 'In vitro antiplasmodial activity (IC50) against Plasmodium falciparum wtTM4/8.2',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum Dd2 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum DEV after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum NIC after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 7G8 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum W2 harboring polymorphic DHFR after 72 hrs by SYBR green assay',\n",
       " 'Inhibition of the S108N mutant of dihydrofolate reductase (DHFR)',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum AL2 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum KB8 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum JON after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum XD8 after 72 hrs by SYBR green assay',\n",
       " 'Inhibitory activity against dihydrofolate reductase (DHFR) of Plasmodium berghei',\n",
       " 'Antimalarial activity against pyrimethamine-sensitive Plasmodium falciparum 3D7 expressing wild type DHFR by [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibitory activity against quadruple mutant dihydrofolate reductase (N51I C59R S108N I164L DHFR), relative to trimethoprim',\n",
       " 'Inhibitory activity against triple mutant dihydrofolate reductase (C59R S108 NI164L DHFR), relative to trimethoprim',\n",
       " 'Compound was tested for its inhibition against dihydrofolate reductase enzyme of Plasmodium berghei',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum KC5 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum KA6 after 72 hrs by SYBR green assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum WC4 after 72 hrs by SYBR green assay',\n",
       " 'Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR)',\n",
       " 'Inhibitory activity against quadruple mutant dihydrofolate reductase (N51I C59R S108N I164L DHFR)',\n",
       " 'Inhibitory activity against dihydrofolate reductase (DHFR) enzyme from Plasmodium berghei',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum AUD after 72 hrs by SYBR green assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum D6 by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against Plasmodium falciparum TM91C235 by [3H]hypoxanthine uptake',\n",
       " 'Inhibition of Plasmodium falciparum KAS3 expressed in Escherichia coli assessed as transfer of [1-14C]acetyl-CoA to [1-14C]acetyl-ACP',\n",
       " 'Therapeutic index, ratio of IC50 for mice (Mus musculus) J774.G8 cells to IC50 for chloroquine-sensitive Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against Plasmodium berghei in mice (Mus musculus) by parenteral route and change in mean survival time in days was determined at 40 mg/kg subcutaneous dose ; 3 cured at 60 days post infection',\n",
       " 'In Vitro inhibition of Heme Oxygenase in Cell-free parasite Plasmodium yoelii at concentration 50 uM',\n",
       " 'In Vitro evaluation on percentage inhibition in Heme Oxygenase at concentration 100(uM) of Cell-free parasite Plasmodium yoelii',\n",
       " 'Percentage influence on cellular glutathione reductase activity',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 320 mg/kg.',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 20 mg/kg subcutaneous dose',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 160 mg/kg; 3 survived after 60 days of postinfection',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 160 mg/kg',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 40 mg/kg subcutaneous dose',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 640 mg/kg; 5 survived after 60 days of postinfection',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose',\n",
       " 'Daily dose required for 90% parasitaemia in trophozoite induced Plasmodium berghei in 21 mice',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum schizonts assessed as change in parasitemia at IC50 concentration treated until all schizonts had burst and invasion was assumed to have occurred by Giemsa staining-based microscopy relative to control',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs by lactate dehydrogenase assay',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 after 48 hrs by lactate dehydrogenase assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum schizonts assessed as parasitemia at IC50 concentration treated until all schizonts had burst and invasion was assumed to have occurred by Giemsa staining-based microscopy (Rvb = 8.83%)',\n",
       " 'Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum K1 to IC50 for chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum TM4/8.2 infected Vero cells',\n",
       " 'Binding affinity towards wild-type dihydrofolate reductase of Plasmodium falciparum.',\n",
       " 'Binding affinity towards mutant dihydrofolate reductase (A16V+S108T DHFR) of Plasmodium falciparum.',\n",
       " 'In vitro cytotoxicity against Plasmodium falciparum infected BC cell line.',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum Csl-2 infected BC cells',\n",
       " 'Binding affinity towards mutant dihydrofolate reductase (C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum Csl-2 infected KB cells',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum V1/S infected Vero cells',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum TM4/8.2 infected BC cells',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum V1/S infected KB cells',\n",
       " 'Ratio of binding affinity for mutant (C59R+S108N+I164L) to that of wild type dihydrofolate reductase',\n",
       " 'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase A16V/S108T (T9/94RC17) mutant',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum V1/S infected BC cells',\n",
       " 'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase C59R/S108N (K1CB1) mutant',\n",
       " 'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase N51I/C59R/S108N (W2)',\n",
       " 'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N DHFR) of Plasmodium falciparum',\n",
       " 'In vitro cytotoxicity against Plasmodium falciparum infected vero cell line.',\n",
       " 'Ratio of binding affinity for mutant (N51I+C59R+S108N+I164L) to that of wild type dihydrofolate reductase',\n",
       " 'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase wild type (TM4/8.2)',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum Csl-2 infected Vero cells',\n",
       " 'Relative antiplasmodial activity to cytotoxicity in Plasmodium falciparum TM4/8.2 infected KB cells',\n",
       " 'Ratio of binding affinity for mutant (N51I+C59R+S108N) to that of wild type dihydrofolate reductase',\n",
       " 'Ratio of binding affinity for mutant (A16V+S108T) to that of wild type dihydrofolate reductase',\n",
       " 'Binding affinity towards mutant dihydrofolate reductase (N51I+C59R+S108N+I164L DHFR) of Plasmodium falciparum',\n",
       " 'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase CN51I/C59R/S108N/I164L (V1/S) mutant',\n",
       " 'In vitro cytotoxicity against Plasmodium falciparum infected KB cell line',\n",
       " 'In vitro anti-plasmodial activity against Plasmodium falciparum dihydrofolate reductase C59R+S108N/I164L (Csl-2) mutant',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       " 'Inhibition of FabI',\n",
       " 'Inhibition of FabG at 100 uM',\n",
       " 'Inhibition of FabZ at 100 uM',\n",
       " 'Inhibition of Plasmodium falciparum cyclin-dependent kinase',\n",
       " 'PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596]',\n",
       " 'In vitro inhibitory activity against chloroquine-resistant Plasmodium falciparum NF54-R in blood',\n",
       " 'In vitro inhibitory activity against hepatic stages of Plasmodium yoelii yoelii 265 BY',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 3D7 infected in RBCs by firefly luciferase reporter gene assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6',\n",
       " 'Antimalarial activity against Plasmodium falciparum NF54',\n",
       " 'In vitro inhibitory activity against hepatic stages of Plasmodium yoelii yoelii 265 BY; No data',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 rings after 48 hrs by FACS analysis',\n",
       " 'PubChem BioAssay. Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid: Hit Validation with Dd2 at 96hr using Flow Cytometry.   (Class of assay: confirmatory) ',\n",
       " 'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       " 'PubChem BioAssay. Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid: Hit Validation with 3D7 at 96 hr using Flow Cytometry.   (Class of assay: confirmatory) ',\n",
       " 'PubChem BioAssay. Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid: Hit Validation at 96 hr.   (Class of assay: confirmatory) ',\n",
       " 'Inhibition of PSAC-mediated sorbitol uptake in erythrocytes infected with Plasmodium falciparum HB3 at 100 to 5000 uM by osmotic lysis half-time determination assay',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as reduction of hemozoin formation at IC50 after 48 hrs relative to control',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as inhibition of sorbitol-induced hemolysis at 10 uM after 15 min by spectrophotometry',\n",
       " 'Inhibition of PSAC-mediated sorbitol uptake in erythrocytes infected with leupeptin resistant-Plasmodium falciparum HB3-leuR1 by osmotic lysis half-time determination assay',\n",
       " 'Minimum inhibitory concentration against schizont maturation of Plasmodium falciparum NF54 ring stage after 40 h',\n",
       " 'Antimalarial activity as survivor number at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Minimum inhibitory concentration against schizont maturation in Plasmodium falciparum NF-54',\n",
       " 'Antimalarial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green based fluorescence assay',\n",
       " 'Inhibition constant against wild-type PfDHFR (Plasmodium falciparum dihydrofolate reductase)',\n",
       " 'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone1 bearing P-type ATPase4 I398F and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 160 mg/kg after subcutaneous administration; no data',\n",
       " 'Growth inhibition of Plasmodium falciparum Dd2 ring stage infected erythrocytes after 72 hrs by DAPI fluorimetry',\n",
       " 'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone2 bearing P-type ATPase4 T418N and P990R mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       " 'Antimalarial activity as inhibition of schizont maturation against Plasmodium malariae Thai after 40 - 70 hrs',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 40 mg/kg; 1 survived after 60 days of postinfection',\n",
       " 'Ratio of IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R, T61M and S117N mutant to IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR',\n",
       " 'Ratio of IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S117N mutant to IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR',\n",
       " 'OSM: Inhibition of Plasmodium falciparum 3D7 growth using a SYBR green I fluorescence based assay. GSK Tres Cantos.',\n",
       " 'Inhibition of the S108N mutant of dihydrofolate reductase (DHFR) relative to Pyr.',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at dosage of 320 mg/kg after subcutaneous administration;; no data',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 20 mg/kg.',\n",
       " 'Inhibition of Plasmodium falciparum DHFR assessed as oxidation of NADPH to NADP+ after 15 mins spectrophotometric assay',\n",
       " 'Inhibition of WR99210-resistant form-3 Plasmodium falciparum N51I, C59R, N108T, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey Vero cells to IC50 for chloroquine-sensitive Plasmodium falciparum D6',\n",
       " 'In vitro relative antiplasmodial activity (IC50) compared to Pyr against Plasmodium falciparum TM4/8.2 wild-type',\n",
       " 'Antiparasitemia activity against Plasmodium berghei infected mice (Mus musculus) at 30 mg/kg peroral dose for 4 days',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected in red blood cells up to 19 uM after 72 hrs by parasitic LDH assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Thermodynamic dissociation constant of compound for mutant S108 Plasmodium falciparum dihydrofolate reductase; ND=no data',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 320 mg/kg; 3 toxic deaths after 2-5 days of injection',\n",
       " 'Antimalarial activity against Plasmodium falciparum Dd2 in erythrocytes',\n",
       " 'Antimalarial activity against Plasmodium falciparum TM91c235 harboring DHFR F57L, S58R, T61M, S117T mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 40 mg/kg ; 1 cured at 60 days postinjection.',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L, S58R, T61M, S117T mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ATCC 50175 infected in ICR mouse assessed as chemosuppression of parasitemia at 1.2 mg/kg/day, po administered 24 hrs post-treatment measured after 4 days',\n",
       " 'Ratio of Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR) to inhibition of wild type dihydrofolate reductase.',\n",
       " 'Inhibitory concentration against cycloguanil sensitive Plasmodium falciparum FJB-D9 ',\n",
       " 'Ratio of Kd to Ki for Plasmodium falciparum dihydrofolate reductase; ND=no data',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 640 mg/kg ; 1 cured and 2 toxic death',\n",
       " 'HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs in SYBR green fluorescence assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes assessed as decrease in parasitemia after 72 hrs',\n",
       " 'Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes',\n",
       " 'Antimalarial activity against Plasmodium falciparum FC27',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous dose of 10 mg/kg',\n",
       " 'Ratio of Inhibition of the S108N mutant of dihydrofolate reductase (DHFR) to inhibition of wild type dihydrofolate reductase.',\n",
       " 'Antimalarial activity against mefloquine-resistant Plasmodium falciparum W2 after 48 hrs by LDH assay',\n",
       " 'Anti-malarial activity against Plasmodium falciparum Dd2',\n",
       " 'Inhibitory concentration against cycloguanil sensitive Plasmodium falciparum FJB-D4 ',\n",
       " 'Antiplasmodial activity against Plasmodium vivax',\n",
       " 'Antimalarial effect against trophozoite induced Plasmodium berghei in mice (Mus musculus) at dosage of 40 mg/kg after subcutaneous administration; no data',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green fluorescence assay',\n",
       " 'Effective dose against chloroquine-resistant, pyrimethamine-resistant, mefloquine-sensitive Plasmodium falciparum K1',\n",
       " 'Inhibition of pyrimethamine-resistant form-1 Plasmodium falciparum N51I, C59R, S108N, I164L, D187A mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 80 mg/kg subcutaneous dose; no data',\n",
       " 'OSM: Inhibition of Plasmodium falciparum 3D7 growth. IC50 values determined from 21 point dose response curves. Avery Group Griffith.',\n",
       " 'Ratio of IC50 for pyrimethamine-resistant form-3 Plasmodium falciparum N51I, C59R, S108N, I164L, I150V, N182I, N201D mutant to IC50 for Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'Inhibition of pyrimethamine-resistant form-3 Plasmodium falciparum N51I, C59R, S108N, I164L, I150V, N182I, N201D mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Inhibition of WR99210-resistant form-A Plasmodium falciparum DHFR-TS I51N, C59R, N108S, L164I, D54N mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Antimalarial activity against chloroquine-susceptible Plasmodium falciparum D10 asexual erythrocyte forms after 48 hrs by parasite LDH assay',\n",
       " 'Inhibitory concentration sensitive Plasmodium falciparum FJB-D9 ',\n",
       " 'Antimalarial activity against Plasmodium falciparum W2 infected in human erythrocytes assessed as decrease in parasitemia after 72 hrs',\n",
       " 'Inhibition of Plasmodium falciparum DHFR assessed as oxidation of NADPH to NADP+ at 10 uM after 15 mins spectrophotometric assay',\n",
       " 'Inhibitor constant of compound for Plasmodium falciparum dihydrofolate reductase',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       " 'Effective dose against chloroquine-resistant, pyrimethamine-resistant, mefloquine-sensitive Plasmodium falciparum W2; Not determined',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 160 mg/kg ; 5 cured at 60 days postinjection.',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after 20 mg/kg subcutaneous dose',\n",
       " 'Antiparasitemia activity against Plasmodium berghei infected mice (Mus musculus) at 30 mg/kg subcutaneous dose for 4 days',\n",
       " 'Antimalarial activity against Plasmodium falciparum W2 as reduced [3H]hypoxanthine uptake after 72 hrs',\n",
       " 'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with single S108T mutation',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in red blood cells after 72 hrs by parasitic LDH assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 3D7A assessed as inhibition of [3H]hypoxanthine incorporation incubated for 24 hrs prior to [3H]hypoxanthine addition measured after 24 hrs by beta scintillation counting',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in type B+ human erythrocytes assessed as inhibition of sorbitol-induced hemolysis at 10 nM after 15 min by spectrophotometry',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 5 mg/kg.',\n",
       " 'In vitro minimum inhibitory concentration against Plasmodium falciparum NF54 over 40 hours',\n",
       " 'Inhibition of WR99210-resistant form-1 Plasmodium falciparum I51N, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum K1',\n",
       " 'Inhibition of pyrimethamine-resistant form-1 Plasmodium falciparum N51I, C59R, S108N, I164L, D187A mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with quadruple (N51I + C59R + S108N + I164L) mutations',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 1.25 mg/kg.',\n",
       " 'Antimalarial activity against multidrug-resistant Plasmodium falciparum TM91C235 assessed as inhibition of [3H]hypoxanthine uptake in presence of 1 mM folinic acid',\n",
       " 'Ratio of IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L, S58R, T61M, S117T mutant to IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ATCC 50175 infected in ICR mouse assessed as parasitemia at 1.2 mg/kg/day, po pretreated for 4 days before infection and measured after 72 hrs (Rvb = 4.6+/-0.21 %)',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs in SYBR green fluorescence assay',\n",
       " 'Selectivity ratio of Ki for human recombinant DHFR to Ki for wild type Plasmodium falciparum DHFR',\n",
       " 'Inhibition of the C59R+S108N mutant of dihydrofolate reductase (DHFR) relative to Pyr.',\n",
       " 'Inhibition against Plasmodium falciparum Dd2 in erythrocytes in semiautomated micro dilution assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum',\n",
       " 'Ratio of IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R and S117N mutant to IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 640 mg/kg; 1 survived after 60 days of post infection',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum harboring K1 allele group of msp1, 3D7 allele group of msp2 gene and 94 bp of 7A11, 196bp of C4M79 and 336bp of C4M69 locus measured on day 23 by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ATCC 50175 infected in ICR mouse assessed as parasitemia at 1.2 mg/kg/day, po administered 24 hrs post-treatment measured after 4 days (Rvb = 56.3+/-0.16 %)',\n",
       " 'NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration',\n",
       " 'Antimalarial activity against Plasmodium falciparum Pf3D70087/N9 infected in immunodeficient HM-beta2 m null mouse after 7 days',\n",
       " 'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-resistant Plasmodium falciparum W2',\n",
       " 'Inhibitory activity against Plasmodium falciparum Dd2 in erythrocytes by semiautomated micro dilution',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 in erythrocytes',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ATCC 50175 infected in ICR mouse assessed as chemosuppression of parasitemia at 1.2 mg/kg/day, po pretreated for 4 days before infection and measured after 72 hrs',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum D6 after 72 hrs by SYBR green fluorescence assay',\n",
       " 'Antimalarial activity against mefloquine-resistant, chloroquine-sensitive Plasmodium falciparum D6 assessed as inhibition of [3H]hypoxanthine uptake in presence of 1 mM folinic acid',\n",
       " 'Antimalarial activity as survivor numbers at day 60 for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 320 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Antimalarial activity against Plasmodium falciparum FCR3',\n",
       " 'Ratio of IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L and S117N mutant to IC50 for Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Selectivity ratio of IC50 for plasmodium falciparum 3D7A to IC50 for human 5HT2c receptor',\n",
       " 'Inhibition of WR99210-resistant form-3 Plasmodium falciparum N51I, C59R, N108T, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'HARVARD: Cytotoxicity in HepG2 cell line',\n",
       " 'Antimalarial activity as toxic deaths 2-5 days post infection for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 320 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Antiplasmodial activity (IC50) compared to Pyr against Plasmodium falciparum K1CB1 DHFR double-mutant (C59R/S108N)',\n",
       " 'Ratio of IC50 for WR99210-resistant form-3 Plasmodium falciparum N51I, C59R, N108T, I164L mutant to IC50 for Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 640 mg/kg subcutaneous dose',\n",
       " 'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum clinical isolate harboring S108N, N51I mutation in DHFR assessed as decrease in parasitaemia',\n",
       " 'Inhibition of Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Inhibition of Plasmodium falciparum DHFR-TS QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Inhibition of pyrimethamine-resistant form-2 Plasmodium falciparum N51I, C59R, S108N, I164L, K96N mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Effective dose against chloroquine-resistant, pyrimethamine-resistant, mefloquine-resistant Plasmodium falciparum Dd2',\n",
       " 'Inhibition of WR99210-resistant form-2 Plasmodium falciparum N51I, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 80 mg/kg ; 3 cured at 60 days postinjection.',\n",
       " 'Binding affinity was evaluated as inhibition of recombinant wild type (WT) Plasmodium falciparum DHFR-TS.',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 2.5 mg/kg',\n",
       " 'Selectivity ratio of Ki for recombinant Plasmodium falciparum V1/S DHFR S108N, N51I, C59R, I164L mutant to Ki for wild type Plasmodium falciparum DHFR',\n",
       " 'Antimalarial activity as survivor numbers at day 60 against drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 160 mg/kg subcutaneous dose after 72 hr',\n",
       " 'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with double (A16V + S108T) mutations',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum Dd2 assessed as inhibition of [3H]hypoxanthine incorporation incubated for 24 hrs prior to [3H]hypoxanthine addition measured after 24 hrs by beta scintillation counting',\n",
       " 'Ratio of inhibitions against mutant and wild type (WT) Plasmodium falciparum DHFR-TS.',\n",
       " 'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum clinical isolate harboring S108N, C59R mutation in DHFR assessed as decrease in parasitaemia',\n",
       " 'In vitro antimalarial activity for DHFR wild-type, chloroquine and pyrimethamine-sensitive Plasmodium falciparum D6',\n",
       " 'Ratio of Kd to Ki for mutant S108 N Plasmodium falciparum dihydrofolate reductase; ND=no data',\n",
       " 'In vitro inhibition of Plasmodium falciparum HB3 (S108N) culture',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 2.5 mg/kg.',\n",
       " 'Effective dose against chloroquine-sensitive, pyrimethamine-sensitive, mefloquine-sensitive Plasmodium falciparum 3D7',\n",
       " 'Inhibition of WR99210-resistant form-1 Plasmodium falciparum I51N, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Inhibition of WR99210-resistant form-2 Plasmodium falciparum N51I, C59R, N108S, I164L mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Inhibition of pyrimethamine-resistant form-2 Plasmodium falciparum N51I, C59R, S108N, I164L, K96N mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum VS/1 by [3H]hypoxanthine incorporation assay',\n",
       " 'Binding affinity to recombinant Plasmodium falciparum V1/S DHFR S108N, N51I, C59R, I164L mutant by competitive binding assay',\n",
       " 'Antimalarial activity against trophozoite-induced Plasmodium berghei in mice (Mus musculus)',\n",
       " 'Growth inhibition of Plasmodium falciparum HB3 ring stage in infected erythrocytes after 72 hrs in DAPI fluorimetry',\n",
       " 'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with single A16V mutation',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 320 mg/kg subcutaneous dose',\n",
       " 'Inhibitor constant of compound for mutant S108 N Plasmodium falciparum in dihydrofolate reductase',\n",
       " 'Inhibitory concentration against multidrug-resistant Plasmodium falciparum Dd2.',\n",
       " 'Antimalarial activity against NITD609-resistant Plasmodium falciparum Dd2 Clone3 bearing P-type ATPase4 D1247Y mutations after 72 hrs by SYBR green based fluorescence assay',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 80 mg/kg; 3 survived after 60 days of postinfection',\n",
       " 'Selectivity ratio of IC50 for Plasmodium falciparum Dd2 to IC50 for Plasmodium falciparum 3D7A',\n",
       " 'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum V1/S harboring S108N, N51I, C59R, I164L mutation in DHFR assessed as decrease in parasitaemia',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 infected in human A positive erythrocytes by [3H]hypoxanthine uptake assay in presence of serum in medium',\n",
       " 'Antimalarial activity against Plasmodium falciparum PfV1S0176/N10 infected in immunodeficient HM-IL2Rgamma null mouse after 7 days',\n",
       " 'Effective dose against chloroquine-sensitive, pyrimethamine-sensitive, mefloquine-sensitive Plasmodium falciparum HB3',\n",
       " 'OSM: Inhibition of Plasmodium falciparum K1 growth. IC50 values determined from 21 point dose response curves. Avery Group Griffith.',\n",
       " 'OSM: HEK293 cytotoxicity assay. IC50 values determined from 21 point dose response curves. Avery Group Griffith.',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) at 5 mg/kg subcutaneous dose',\n",
       " 'Ratio of IC50 for pyrimethamine-resistant form-2 Plasmodium falciparum N51I, C59R, S108N, I164L, K96N mutant to IC50 for Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'Ratio of IC50 for WR99210-resistant form-2 Plasmodium falciparum N51I, C59R, N108S, I164L mutant to IC50 for Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'Inhibition of pyrimethamine-resistant form-3 Plasmodium falciparum N51I, C59R, S108N, I164L, I150V, N182I, N201D mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum Pf3D70087/N9 infected in immunodeficient HM-IL2Rgamma null mouse after 7 days',\n",
       " 'Ratio of IC50 for WR99210-resistant form-1 Plasmodium falciparum I51N, C59R, N108S, I164L mutant to IC50 for Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'Ratio of IC50 for WR99210-resistant form-A Plasmodium falciparum DHFR-TS I51N, C59R, N108S, L164I, D54N mutant to IC50 for Plasmodium falciparum DHFR-TS QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'In vitro inhibition of Plasmodium falciparum K1 (S108N + C59R) culture',\n",
       " 'Inhibition of Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Antimalarial activity against Plasmodium falciparum Mad20',\n",
       " 'Antimalarial activity against liver stages of Plasmodium cynomolgi infected in human HepG2 cells assessed as growth inhibition of hepatic parasite after 3 days',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 10 mg/kg.',\n",
       " 'Antimalarial effect against trophozoite-induced Plasmodium berghei in mice (Mus musculus) after subcutaneous administration dose of 640 mg/kg; 2 toxic deaths after 2-5 days of injection',\n",
       " 'Mean survival time against trophozoite induced Plasmodium berghei in mice minus control was evaluated at a dose 320 mg/kg ; 2 cured and 3 toxic death',\n",
       " 'Antimalarial activity as toxic deaths 2-5 days post infection for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 640 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax wild type DHFR infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Growth inhibition of Plasmodium falciparum 3D7 ring stage in infected erythrocytes after 72 hrs in DAPI fluorimetry',\n",
       " 'Binding affinity was evaluated as inhibition of mutant (C59R + S108N) Plasmodium falciparum DHFR-TS.',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR S58R, T61M and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Antimalarial activity against Plasmodium falciparum HB3',\n",
       " 'Thermodynamic dissociation constant of compound for Plasmodium falciparum dihydrofolate reductase; ND=no data',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 harboring Plasmodium vivax DHFR F57L and S117N mutant infected in RBCs assessed as inhibition of [3H]hypoxanthine incorporation after 72 hrs',\n",
       " 'Inhibition of WR99210-resistant form-A Plasmodium falciparum DHFR-TS I51N, C59R, N108S, L164I, D54N mutant expressed in Escherichia coli BL21(DE3) by Michaelis-Menten based competitive inhibition assay',\n",
       " 'Ratio of IC50 for Plasmodium falciparum TM91c235 harboring DHFR F57L, S58R, T61M, S117T mutant to IC50 for Plasmodium falciparum D6',\n",
       " 'Inhibition constant against PfDHFR (Plasmodium falciparum dihydrofolate reductase) with triple (C59R + S108N + I164L) mutations',\n",
       " 'Compound was tested in vivo for antimalarial activity against Plasmodium berghei in mice (Mus musculus) after 6 days of administration (ED90 is the dose necessary to reduce the percentage of infected cells to 10% of the level found in the infected untreated controls)',\n",
       " 'Antimalarial activity as change in MST for drug-sensitive Plasmodium berghei infected mice (Mus musculus) at 40 mg/kg subcutaneous dose over 72 hr',\n",
       " 'Antimalarial activity against pyrimethamine-resistant Plasmodium falciparum clinical isolate harboring S108N, N51I, C59R mutation in DHFR assessed as decrease in parasitaemia',\n",
       " 'Inhibition of Plasmodium falciparum DHFR-TS QM template N51I, C59R, S108N, I164L mutant expressed in Escherichia coli BL21(DE3)',\n",
       " 'Binding affinity to wild type Plasmodium falciparum DHFR by competitive binding assay',\n",
       " 'Inhibition of the wild-type dihydrofolate reductase (DHFR)relative to Pyr.',\n",
       " 'Antimalarial activity against Plasmodium falciparum NF54 after 36-40 hrs',\n",
       " 'Ratio of IC50 for pyrimethamine-resistant form-1 Plasmodium falciparum N51I, C59R, S108N, I164L, D187A mutant to IC50 for Plasmodium falciparum DHFR QM template N51I, C59R, S108N, I164L mutant',\n",
       " 'DNDI: Inhibition of Human African Trypanosomiasis (HAT), STIB 795, in vitro',\n",
       " 'DNDI: Cytotoxicity against human MRC-5 lung fibroblast cells.',\n",
       " 'Increase in PfCRT expression in chloroquine-resistant Plasmodium falciparum R1H6/2 by Western blot relative to untreated control',\n",
       " 'Increase in PfCRT expression chloroquine-sensitive Plasmodium falciparum K1Hf by Western blot relative to untreated control',\n",
       " 'Increase in PfCRT expression in chloroquine-sensitive Plasmodium falciparum K1AM by Western blot relative to untreated control',\n",
       " 'Increase in Pgh1 expression in chloroquine-resistant Plasmodium falciparum R1H6/2 by Western blot relative to untreated control',\n",
       " 'Increase in Pgh1 expression chloroquine-sensitive Plasmodium falciparum K1Hf by Western blot relative to untreated control',\n",
       " 'Increase in Pgh1 expression in chloroquine-sensitive Plasmodium falciparum K1AM by Western blot relative to untreated control',\n",
       " 'PUBCHEM_BIOASSAY: Dose Response orthogonal assay utilizing the direct end-point detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696]',\n",
       " 'PUBCHEM_BIOASSAY: Human Glucose-6-Phosphate Dehydrogenase Dose Response Selectivity Assay for Inhibitors of Plasmodium falciparum Glucose-6-Phosphate Dehydrogenase.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696]',\n",
       " 'PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696]',\n",
       " 'PUBCHEM_BIOASSAY: Dose Response orthogonal kinetic assay utilizing the direct detection of NADPH for uHTS small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504690, AID504696]',\n",
       " 'Percent inhibition of hypoxanthine uptake by Plasmodium berghei',\n",
       " 'Percent inhibition of adenosine uptake by Plasmodium berghei',\n",
       " 'Inhibition of Tween 20-induced beta-hematin formation by colorimetric assay',\n",
       " 'Effective concentration against Plasmodium falciparum W2',\n",
       " 'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 72 hrs',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 48 hrs by [G-3H]hypoxanthine uptake',\n",
       " 'Selectivity index, ratio of TC50 for hepatocytes to IC50 for Plasmodium yoelii ',\n",
       " 'Antimicrobial activity against chloroquine-resistant Plasmodium falciparum W2 after 72 hrs',\n",
       " 'Effective concentration for Plasmodium falciparum 3D7',\n",
       " 'Antimicrobial activity against Plasmodium yoelii 265 liver infected in mammalian hepatocytes after 48 hrs',\n",
       " 'Inhibitory concentration IC50 against Plasmodium falciparum K1 by [3H]hypoxanthine uptake over 24 hr',\n",
       " 'Inhibition of [3H]hypoxanthine incorporation in Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine incorporation',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum PoW',\n",
       " 'Inhibition of FabZ',\n",
       " 'Inhibition of FabI at 100 uM',\n",
       " 'Antimalarial activity against liver stages of Plasmodium berghei',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA expressing GFP infected in C57BL/6 mouse assessed as reduction of liver infection at 200 mg/kg, ip incubated for 6 hrs prior to sporozoite inoculation measured after 40 hrs by qRT PCR',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum 3D7',\n",
       " 'PUBCHEM_BIOASSAY: Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation.   (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504832, AID504834]',\n",
       " 'Growth inhibition of chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       " 'Inhibition of Plasmodium falciparum-mediated human hemoglobin degradation at 100 uM',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human O+ erythrocytes after 72 hrs by SYBR Green-1 fluorescence based assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum DD2 by [3H]hypoxanthine uptake',\n",
       " 'Inhibition of Plasmodium falciparum DHOD',\n",
       " 'Antimalarial activity against Plasmodium falciparum DD2 expressing Saccharomyces cerevisiae DHOD by [3H]hypoxanthine uptake',\n",
       " 'Inhibition of Plasmodium falciparum NDH2',\n",
       " 'Inhibition of Plasmodium falciparum HGXPRT',\n",
       " 'Ratio of GMP Ki to compound Ki for Plasmodium falciparum HGXPRT',\n",
       " 'Inhibition of Plasmodium vivax HGPRT',\n",
       " 'In vitro inhibition against chloroquine-sensitive Plasmodium falciparum K39; Range 0.1-0.4 uM',\n",
       " 'In vitro inhibition against chloroquine-resistant Plasmodium falciparum V1/S; Range 0.1-0.4 uM',\n",
       " 'Inhibition of Plasmodium falciparum ENR',\n",
       " 'Inhibition of Plasmodium falciparum ENR in presence of triclosan',\n",
       " 'Antiprotozoal activity against Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54',\n",
       " 'Inhibition of FabG',\n",
       " 'Inhibition of Plasmodium falciparum ENR using NADH substrate',\n",
       " 'Inhibition of Plasmodium falciparum ENR using crotonyl-CoA substrate',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D6',\n",
       " 'Inhibition of Plasmodium falciparum FabI',\n",
       " 'HARVARD: Inhibition of blood stage Plasmodium falciparum Dd2 infection',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs by Malstat reagent method',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for Plasmodium falciparum D6',\n",
       " 'Antiplasmodial activity after 48 hrs against chloroquine-resistant Plasmodium falciparum K1 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH reporter assay',\n",
       " 'Antiparasitic activity against Plasmodium falciparum K1',\n",
       " 'In vitro antiparasitic activity against chloroquine-resistant Plasmodium falciparum Indochina I',\n",
       " 'Antimalarial activity against Plasmodium falciparum',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 as LDH activity',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH reporter assay',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 in erythrocytes by LDH reporter assay',\n",
       " 'Selectivity index, ratio of IC50 for rat L6 cells to IC50 for Plasmodium falciparum K1',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum W2 by flow cytometry',\n",
       " 'Selectivity index, ratio for IC50 of rat L6 cells to IC50 of chloroquine-resistant Plasmodium falciparum K1',\n",
       " 'Selectivity index, ratio of IC50 for rat L6 cells to IC50 for chloroquine-resistant Plasmodium falciparum K1',\n",
       " 'Selectivity ratio for IC50 of chloroquine-resistant Plasmodium falciparum K1 over Trypanosoma brucei rhodesiense STIB900',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs by Malstat reagent method',\n",
       " 'Antimalarial activity against erythrocytic stage of Plasmodium falciparum NF54 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counting analysis',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for chloroquine-sensitive Plasmodium falciparum D6',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum K1',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum W2 in erythrocytes by LDH reporter assay',\n",
       " 'Antimalarial activity against chloroquine and pyrimethamine -resistant Plasmodium falciparum K1 after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibition of Plasmodium falciparum recombinant falcipain-2 using Cbz-Leu-Arg-AMC as substrate by standard fluorescence assay',\n",
       " 'In vitro inhibitory activity against Plasmodium falciparum; Not determined',\n",
       " 'Antiplasmodial activity after 48 hrs against chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 after 72 hrs by alamar blue assay',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum K1 infected in human RBC after 48 hrs by [3H]-hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum K1 infected in human red blood cells assessed as [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for Plasmodium falciparum W2',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FcB1/Colombia infected in human A+ve erythrocytes assessed as inhibition of [G-3H]hypoxanthine uptake preincubated for 24 hrs prior to [G-3H]hypoxanthine addition measured after 18 hrs by liquid scintillation counting',\n",
       " 'Selectivity index, ratio of IC50 for Trypanosoma brucei rhodesiense STIB900 to IC50 for Plasmodium falciparum K1',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 by pLDH activity',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH reporter assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH activity',\n",
       " 'In vitro antiprotozoal activity for Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against Plasmodium falciparum W2 after 72 hrs by alamar blue assay',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum W2 by pLDH activity',\n",
       " 'In vitro antiparasitic activity against chloroquine-sensitive Plasmodium falciparum Haiti 135',\n",
       " 'Antimalarial activity against drug -sensitive Plasmodium falciparum NF54 after 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by LDH assay',\n",
       " 'Selectivity index, ratio of IC50 for rat L6 cells to IC50 for Plasmodium falciparum NF54',\n",
       " 'In vitro inhibitory activity for Plasmodium falciparum; Not tested',\n",
       " 'Antiprotozoal activity as cell damage against Plasmodium berghei',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 infected in human erythrocytes after 48 hrs assessed as [3H]hypoxanthine incorporation by liquid scintillation counting',\n",
       " 'Inhibition of Plasmodium falciparum recombinant falcipain-3 by standard fluorescence assay',\n",
       " 'Selectivity ratio of IC50 for Trypanosoma brucei rhodesiense STIB900 to IC50 for Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against Plasmodium berghei schizonts isolated from parasitized erythrocytes infected Wistar rat measured 16 hrs post compound exposure',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 by LDH assay',\n",
       " 'In vivo antimalarial activity against Plasmodium falciparum',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 0.1 mg/kg/day',\n",
       " 'The compound was tested for the dose required to cause 50% suppression of Plasmodium berghei growth in mice.',\n",
       " 'Parasitaemia (%) in tail blood smears from Plasmodium berghei infected ICR mice (Mus musculus) at 0.1-mg/kg/day for 4 days',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 1.0 mg/kg/day',\n",
       " 'Percent parasitaemia in tail blood smears from Plasmodium berghei infected ICR mice (Mus musculus) at 0.5-mg/kg/day after 4 days',\n",
       " 'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 5 mg/kg/day after 4 days',\n",
       " 'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 2 mg/kg/day after 4 days',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 5 mg/kg/day',\n",
       " 'Parasitaemia (%) in tail blood smears from Plasmodium berghei infected ICR mice (Mus musculus) after 4 days',\n",
       " 'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 1.0 mg/kg/day after 4 days',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 2 mg/kg/day',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 0.5 mg/kg/day',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 10 mg/kg/day',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at different doses 20 mg/kg/day',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as parasite-specific LDH release after 72 hrs by Malstat assay',\n",
       " 'Antiplasmodial activity against blood stage forms of chloroquine-sensitive Plasmodium falciparum 3D7 assessed as dysfunctional intracellular membrane biosynthesis at IC50 after 72 hrs by electron microscopy',\n",
       " 'Antimalarial activity against erythrocyte stage Plasmodium falciparum 3D7',\n",
       " 'Antiplasmodial activity against multi drug-resistant Plasmodium falciparum K1 in erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-resistant erythrocytic stage of Plasmodium falciparum K1 assessed as inhibition of [3H}hypoxanthine incorporation after 24 hrs by liquid scintillation counter',\n",
       " 'Antimalarial activity against Plasmodium falciparum Dd2 expressing katG',\n",
       " 'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against Plasmodium falciparum Dd2',\n",
       " 'Antimalarial activity against Plasmodium falciparum Dd2 with pLN-hrp3-katG-V5 insertion at attB site',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 expressing katG',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 with pLN-hrp3-katG-V5 insertion at attB site',\n",
       " 'Inhibitory concentration (IC50) against chloroquine-sensitive falciparum sierra leone D-8 in human malaria',\n",
       " 'Inhibitory concentration (IC50) against chloroquine-resistant falciparum Indochina W2 in human malaria',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D10',\n",
       " 'HARVARD: Inhibition of blood stage Plasmodium falciparum 3D7 infection',\n",
       " 'Binding affinity to Plasmodium falciparum spermidine synthase by saturation transfer difference-NMR experiment relative to methylthioadenosine',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum K1 in [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibition of Plasmodium falciparum falcipain 2 assessed as benzyloxycarbonyl-Phe-Leu-7-amino-4-methylcoumarin substrate hydrolysis after 30 mins by spectrofluorometry analysis',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in erythrocytes assessed as inhibition of sorbitol-induced hemolysis after 15 mins',\n",
       " 'Antimalarial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 after 24 hrs by [3H]hypoxanthine uptake',\n",
       " 'In Vitro evaluation on percentage inhibition in Heme Oxygenase at concentration 100 (uM) of Cell-free parasite Plasmodium yoelii',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes by SYBR green assay',\n",
       " 'Chemosensitizing activity after 72 hrs against chloroquine-resistant Plasmodium falciparum Dd2 infected human erythrocytes as IC50 ratio chloroquine +/- 500 nM by SYBR green assay',\n",
       " 'Chemosensitizing activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes as IC50 ratio chloroquine +/- 500nM by SYBR green assay',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum Dd2 infected human erythrocytes by SYBR green assay',\n",
       " 'In vitro inhibitory concentration against chloroquine-resistant Plasmodium falciparum K1',\n",
       " 'In vitro inhibitory concentration against chloroquine-sensitive Plasmodium falciparum HB3',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 after 24 hrs as reduced [3H]phenylalanine uptake',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum GCO3 after 72 hrs by SYBR green 1 assay',\n",
       " 'Inhibitory concentration against Plasmodium falciparum W2 Indochina',\n",
       " 'Antimalarial activity against morfloquine-resistant Plasmodium falciparum TM91C235 assessed as [3H]hypoxanthine incorporation',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 assessed as incorporation of [3H]hypoxanthine after 48 hrs by scintillation counter',\n",
       " 'Selectivity index, ratio of IC50 for human MRC5 cells to IC50 for chloroquine-resistant Plasmodium falciparum PFB',\n",
       " 'Antimicrobial activity against Plasmodium vivax at the ring stage measured after 30 hrs by microscopy',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum W2 in human erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against Plasmodium falciparum assessed as resistant isolates',\n",
       " 'Selectivity for chloroquine-resistant Plasmodium falciparum Dd2 over chloroquine-sensitive Plasmodium falciparum HB3 as IC50 ratio by SYBR green assay',\n",
       " 'Concentration required for 50% decrease in IC50 for chloroquine; Not determined',\n",
       " 'Selectivity index, ratio of TC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for Plasmodium falciparum D6',\n",
       " 'The compound was tested in vivo antimalarial response against multidrug-resistant Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 48 (mg/kg/day) after 4 day',\n",
       " 'Antimicrobial activity against chloroquine-resistant Plasmodium chabaudi ASCQ infected in NIH mice (Mus musculus) at 2.5 mg/kg, perorally administered after 72 hrs post inoculation measured on day 4 post infection',\n",
       " 'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 infected mice (Mus musculus) macrophage by reporter dye assay',\n",
       " 'Selectivity index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum K1 to IC50 for chloroquine-sensitive Plasmodium falciparum NF54',\n",
       " 'In vitro inhibitory activity against Chloroquine-sensitive Plasmodium falciparum NF54 as [3H]hypoxanthine incorporation',\n",
       " 'In vitro antimalarial activity as schizont maturation against drug-sensitive Plasmodium falciparum',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in human O+ RBC by parasite LDH assay',\n",
       " 'Antiparasitic activity against Plasmodium falciparum K1 infected in rat L6 cells assessed as inhibition of parasite growth preincubated for 48 hrs before [3H]hypoxanthine addition measured after 24 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum FG2 parasite ',\n",
       " 'Antimalarial activity against mefloquine, chloroquine and quinine-resistant Plasmodium falciparum TM91C235',\n",
       " 'Antimalarial activity after 24 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 by [3H]hypoxanthine uptake',\n",
       " 'Selectivity index, ratio of IC50 for human HCT116 cells to IC50 for chloroquine-sensitive Plasmodium falciparum FCA 20/ Ghana',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum 7G8 infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       " 'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 infected in rat L6 cells',\n",
       " 'Anti-infective activity against Plasmodium falciparum W2 in erythrocytes',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum NF54',\n",
       " 'In vitro antimalarial activity against Thai strain of Plasmodium falciparum',\n",
       " 'Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       " 'Selectivity index, Ratio of IC50 in Vero cells to IC50 in chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity as reduced parasitaemia after 6 days against Plasmodium yoelii N67 infected Swiss mice (Mus musculus) at 50 mg/kg/day intraperitoneal dose',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 after 48 hrs',\n",
       " 'Effective subcutaneous dose ED90 against Plasmodium yoelii sspNS',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum L1 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum Bres infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in CD mouse assessed as suppression of parasitemia at 5 mg/kg/day, ip measured on day 5 post-infection by Giemsa staining',\n",
       " 'Antimalarial activity against Plasmodium falciparum K1 assessed as inhibition of [3H] hypoxanthine uptake by liquid scintillation counting',\n",
       " 'Antimalarial activity against Plasmodium falciparum IMT K4 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum K1',\n",
       " 'Antiplasmodial activity against Plasmodium vinckei petteri infected in CD mouse assessed as suppression of parasitemia at 1 mg/kg/day, ip measured on day 5 post-infection by Giemsa staining',\n",
       " 'Antimalarial activity after 48 hrs against Plasmodium falciparum D6 by [3H]hypoxanthine uptake',\n",
       " 'Effect on survival of mice (Mus musculus) infected with Plasmodium berghei at 640 mg/kg, perorally',\n",
       " 'In vitro antimalarial activity against ring stage of chloroquine-resistant Plasmodium falciparum W2 cultured in medium containing 10% human serum assessed as inhibition of parasite growth after 48 hrs by YOYO-1 dye based flow cytometry',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected human erythrocytes after 72 hrs by MSF assay',\n",
       " 'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       " 'Toxicity in Plasmodium berghei NK-65 infected Swiss Webster mouse at 30 mg/kg, ip QD for 3 days',\n",
       " 'Antiplasmodial potency relative to chloroquine in ferriprotoporphyrin biomineralisation assay',\n",
       " 'Antimalarial activity against Plasmodium berghei NK-65 infected in Swiss Webster mouse assessed as mean survival time at 30 mg/kg, ip QD for 3 days administered 2 hrs post infection',\n",
       " 'Antimalarial activity as mean survival days against Plasmodium berghei NK65 infected ICR mice (Mus musculus) at 30 mg/kg/day peroral dose',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Indochina W2 infected human erythrocytes assessed as uptake of PicoGreen after 48 hrs',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 48 hrs',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 infected in erythrocytes after 48 hrs by SYBR Green 1-based fluorescence assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 after 72 hrs by SYBR Green I-based fluorescence assay',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum FCM29 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human A+ erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs by scintillation counting',\n",
       " 'Antiplasmodial activity against Plasmodium berghei ANKA infected in mice (Mus musculus) assessed as mice (Mus musculus) survival at 10 mg/kg, intraperitoneal for 5 consecutive days measured on day 14 post parasitic infection',\n",
       " 'Resistance index was measured as the ratio of IC50 of Plasmodium falciparum W-2 clone / IC50 of P. falciparum D-6 clone',\n",
       " 'Inhibitory activity against chloroquine-resistant Plasmodium falciparum FcB1R',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10 after 48 hrs',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D10 by pLDH assay',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FCR-3 infected in human A positive erythrocytes by [3H]-hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1 assessed as [3H]hypoxanthine incorporation after 48 hrs by beta-counter',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as host survival time at 100 mg/kg, perorally administered as single dose (Rvb = 6 to 7 days)',\n",
       " 'Inhibition of beta-hematin formation at pH 5.0; active',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity against Plasmodium yoelii infected in Swiss mouse assessed as inhibition of beta-hematin formation in plasma after 16 hrs by spectrophotometric analysis',\n",
       " 'Antimalarial activity against Plasmodium falciparum W2 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity against Plasmodium falciparum IMT 10500 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity after 24 hrs against chloroquine-resistant Plasmodium falciparum K1/Thailand by [3H]hypoxanthine uptake',\n",
       " 'Drug level in chloroquine-sensitive Plasmodium falciparum D6 digestive vacuole assessed as ratio of drug level in vacuole to medium at 5 uM after 1 hr',\n",
       " 'Antimalarial activity against asexual blood stage of Plasmodium falciparum 3D7 after 48 hrs by candle jar method',\n",
       " 'Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum Dd2 to IC50 for chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Antimalarial activity against multidrug-resistant Plasmodium falciparum TM91C235',\n",
       " 'Antimicrobial activity against chloroquine-sensitive Plasmodium falciparum D6 by ELISA',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 assessed as inhibition of parasite LDH activity after 72 hrs by spectrophotometry',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum W2 infected in human erythrocytes',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FCR3 Gambia as 24 hrs [3H]hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 after 72 hrs by LDH assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum Dd2',\n",
       " 'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum K1AM by [3H]hypoxanthine incorporation assay',\n",
       " 'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum K1Hf by [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibitory activity against beta-hematin formation',\n",
       " 'Antimalarial activity against Plasmodium falciparum infected in human erythrocytes assessed as growth inhibition by microscopic analysis using giemsa staining',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum W2 infected in RBCs by parasitic LDH release assay',\n",
       " 'Antiparasitic activity against chloroquine-resistant Plasmodium falciparum R1H6/2 pretreated with 0.1 uM phenobarbitone for 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Selectivity index, ratio of ED50 for human KB cells to IC50 for chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 by [3H]hypoxanthine incorporation',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in human erythrocytes after 48 hrs',\n",
       " 'Antimalarial activity as reduced parasitaemia against Plasmodium yoelii 17X infected CD1 mice (Mus musculus) after 4 days',\n",
       " 'Toxicity in Plasmodium berghei infected ICR mice (Mus musculus) dosed intraperitoneally once daily for 4 days by Thompson test',\n",
       " 'Antimalarial schizonticidal activity against Plasmodium falciparum 3D7 infected erythrocytes at 10 ug/ml after 30-39 hrs',\n",
       " 'Selectivity index, ratio of TC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for chloroquine-sensitive Plasmodium falciparum D6',\n",
       " 'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as survival at 10 mg/kg, perorally administered through 7% Tween80/3% Ethanol formulation 24 hrs post infection for 3 days measured 96 hrs post infection',\n",
       " 'Antiplasmodial activity against chloroquine-, pyrimethamine-, proguanil-resistant Plasmodium falciparum K1 infected in A-positive human erythrocytes after 72 hrs by SYBR green 1 fluorescence-based method',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in RBC assessed as parasite LDH activity after 72 hrs',\n",
       " 'Antimalarial activity against atovaquone-resistant Plasmodium falciparum TM90C2B',\n",
       " 'Antimalarial activity as inhibition of schizont maturation against Plasmodium falciparum NF54 after 36 - 40 hrs',\n",
       " 'Antimalarial activity against drug-resistant Plasmodium falciparum TM90C2A',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation incubated for 48 hrs prior to [3H]hypoxanthine addition measured after 48 hrs by liquid scintillation counting',\n",
       " 'Antimalarial activity as mean survival time against Plasmodium yoelii N67 infected Swiss mice (Mus musculus)',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by 1536-well format based SYBR green assay',\n",
       " 'Percent reversal against Plasmodium falciparum W2 at 1 uM DEEA',\n",
       " 'Inhibition of beta-hematin formation using synthetic hemin chloride',\n",
       " 'Inhibitory concentration against Plasmodium falciparum K1 infected erythrocytes',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum C6harboring 7G8 pfcrt allele infected in erythrocytes assessed as [3H]hypoxanthine incorporation',\n",
       " 'Selectivity for chloroquine-resistant Plasmodium falciparum FCB over chloroquine-sensitive Plasmodium falciparum GCO3 as IC50 ratio by SYBR green assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum D6 after 24 hrs by [3H]hypoxanthine uptake',\n",
       " 'Selectivity ratio of IC50 for human HepG2 cells to IC50 for chloroquine-sensitive Plasmodium falciparum 3D7A',\n",
       " 'Antimalarial activity against GFP-transfected Plasmodium berghei strain ANKA infected in NMRI mouse assessed as increase in median survival time at 10 mg/kg/day, po administered as single dose measured measured up to 30 days (Rvb = 5 days)',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 by FACS-based assay',\n",
       " 'Antiplasmodial activity growth inhibition of chloroquine-resistant Plasmodium falciparum BHz 26/86 after 72 hrs',\n",
       " 'In vitro antimalarial activity against chloroquine-resistant Plasmodium falciparum CDC/Indochina III W2',\n",
       " 'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCR3',\n",
       " 'Selectivity index, ratio of CC50 for human HeLa cells to IC50 for Plasmodium falciparum 3D7 ring stage cells',\n",
       " 'Antimalarial activity against Plasmodium berghei GFP ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia dosed in ETPGS formulation 1 day post infection measured 72 hrs post infection',\n",
       " 'Selectivity index, ratio of ED50 for human KB cells to ED50 for Plasmodium falciparum W2',\n",
       " 'Antimalarial activity after 24 hrs against Plasmodium falciparum D6 infected type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum 3D7 by giemsa stain',\n",
       " 'Selectivity index, ratio of TC50 for human HeLa cells to IC50 for Plasmodium falciparum 3D7',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 by [3H]hypoxanthine uptake',\n",
       " 'Selectivity index, ratio of ED50 for human KB cells to IC50 for Plasmodium falciparum D6',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity as reduced parasitaemia after 72 hrs against chloroquine-resistant Plasmodium falciparum 7G8 in human erythrocytes by DAPI stain',\n",
       " 'Antimalarial activity against GFP-transfected Plasmodium berghei strain ANKA infected in NMRI mouse assessed as increase in median survival time at 10 mg/kg/day, ip administered for 4 days measured up to 30 days (Rvb = 5 to 7 days)',\n",
       " 'In vitro antimalarial activity for Plasmodium falciparum TM91C235',\n",
       " 'Inhibitory concentration against Plasmodium falciparum in FACS',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected type A+ human erythrocytes after 24 hrs by [G-3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity as reduced parasitaemia in Plasmodium berghei ANKA 65 infected Swiss CD1 mice (Mus musculus) at 10 mg/kg/day peroral dose then intraperitoneal dose for 4 days',\n",
       " 'Inhibition of Plasmodium falciparum W2 recombinant falcipain-2',\n",
       " 'Antimalarial activity against Plasmodium ovale trophozoite stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       " 'Resistance index, ratio of IC50 for chloroquine-sensitive Plasmodium falciparum D10 to IC50 for chloroquine-resistant Plasmodium falciparum Dd2',\n",
       " 'Antimalarial activity against Plasmodium falciparum K1 intra-erythrocytic form',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Bre1 by hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum assessed as inhibition of merozoite invasion of RBCs at 1 uM after 48 hrs by SYBR green 1 fluorescence-based flow cytometry',\n",
       " 'The compound was tested in vivo antimalarial response against multidrug-resistant Plasmodium yoelii in Swiss mice (Mus musculus) at a dose of 48 (mg/kg/day) after 10 days',\n",
       " 'Antimalarial activity against chloroquine, pyrimethamine, proguanil-resistant Plasmodium falciparum infected in human erythrocytes after 48 hrs by flow cytometry',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 as LDH activity',\n",
       " 'Ratio of IC50 for chloroquine-resistant Plasmodium falciparum W2 to IC50 for chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Selectivity index ratio of IC50 for human MCF7 cells to IC50 for chloroquine-resistant Plasmodium falciparum FcB1',\n",
       " 'Antiplasmodial activity against Plasmodium berghei NK65 infected in Swiss Webster mice (Mus musculus) assessed as average parasitaemia at 200 mg/kg, perorally administered 1 day after infection measured after 14 days post infection',\n",
       " 'Inhibition of Plasmodium falciparum phosphoethanolamine methyltransferase using phospethanolamine as substrate by radiochemical assay in presence of S-adenosylmethionine',\n",
       " 'Selectivity index, ratio of IC50 for human K562 cells to IC50 for chloroquine, pyrimethamine and proguanil-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 infected in human erythrocytes assessed as inhibition of parasite growth after 24 hrs by Geimsa staining based light microscopic analysis',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum W2 by Malstat LDH activity',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA expressing GFP infected in Sprague-Dawley rat assessed as mean survival days of host at 3 mg/kg, po administered as single dose',\n",
       " 'Antimalarial activity against Plasmodium ovale ring stage infected in red blood cells in presence of AB+ human serum by drug susceptibility assay',\n",
       " 'AUC (0 to 42 days) in Paua New Guinean children with uncomplicated malaria at 10 mg/kg daily for 3 days',\n",
       " 'Antimalarial schizonticidal activity against Plasmodium falciparum 3D7 infected erythrocytes at 0.09 ug/ml after 30-39 hrs',\n",
       " 'Antimalarial activity schizonticidal against Plasmodium falciparum 3D7 infected erythrocytes at 0.05 ug/ml after 30-39 hrs',\n",
       " 'Toxicity in Plasmodium berghei ANKA 65 infected Swiss CD1 mice (Mus musculus)',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-resistant Plasmodium falciparum W2 infected human A+ erythrocytes by Makler LDH reporter assay',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in human RBC assessed as inhibition of parasite growth after 72 hrs by lactate dehydrogenase assay',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 infected human erythrocytes as [3H]hypoxanthine uptake',\n",
       " 'Therapeutic index, Cytotoxicity against human KB cells to Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Antimalarial activity after 48 hrs against Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by pLDH assay',\n",
       " 'In vitro antimalarial activity for Plasmodium falciparum BHz26/86',\n",
       " 'Toxicity in mouse infected with Plasmodium berghei assessed as host survival at 100 mg/kg, po administered QD for 3 days measured on day 28',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 as parasite DNA microfluorimetric assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected human erythrocytes',\n",
       " 'Antimalarial activity against Plasmodium falciparum TM91C235',\n",
       " 'Antimalarial activity reduced schizont maturation in Plasmodium berghei at 10 ug/mL after 16 hrs',\n",
       " 'Compound was tested for antimalarial activity in mice (Mus musculus), infected with Plasmodium yoelii NS, activity is expressed as the mortality rate at a concentration of 10 mg/kg. in experiment 1; 5 out of 5',\n",
       " 'Antimalarial activity against Plasmodium falciparum Nigerian',\n",
       " 'Antiparasitic activity against Plasmodium falciparum W2',\n",
       " 'Antimalarial activity as parasitaemia against Plasmodium berghei ANKA infected Swiss albino mice (Mus musculus) at 100 uM/kg intraperitoneal dose after 3 days',\n",
       " 'Antimalarial activity against erythrocytic stage of chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 assessed as inhibition of [3H]-hypoxanthine incorporation incubated for 48 hrs prior to [3H]-hypoxanthine addition measured after 24 hrs by liquid scintillation counting',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in African green monkey (Cercopithecus aethiops) (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs',\n",
       " 'Antimalarial activity against Plasmodium berghei str. ANKA infected in NMRI mouse assessed as mean survival days at 100 mg/kg, po qd for 4 days (Rvb = 7 days)',\n",
       " 'Antiplasmodial activity against Plasmodium berghei liver stage form transfected in human Huh-7 cells assessed as cell viability after 48 hrs by luciferase reporter gene assay',\n",
       " 'Antimalarial activity against multidrug-resistant and atovaquone-sensitive Plasmodium falciparum TM91C235',\n",
       " 'Percent of infected erythrocytes in Blood schzontocidal activity against Plasmodium chabaudi in mice at a concentration of 10 mg/kg/day on day 3',\n",
       " 'In vitro inhibitory concentration against Plasmodium falciparum F32',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 assessed as inhibition of [3H]hypoxanthine incorporation',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum D2',\n",
       " 'In vivo antimalarial activity of compound against Plasmodium berghei in mice (Mus musculus) expressed as mean survival time at 20 mg/kg',\n",
       " 'Antimalarial activity against Plasmodium falciparum infected in human O+ erythrocytes after 48 hrs by HRP2-ELISA method',\n",
       " 'Inhibition of Plasmodium berghei infection in mice (Mus musculus) at 25 mg/kg peroral dose (experiment 3); Not determined',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 assessed as inhibition of schizont maturation at 0.25 ug/ml after 36-40 hrs relative to control',\n",
       " 'Compound was tested for antimalarial activity in mice (Mus musculus), infected with Plasmodium yoelii NS, activity is expressed as the mortality rate at a concentration of 10 mg/kg. in experiment 2; 5 out of 5',\n",
       " 'Antimalarial activity against Plasmodium yoelii nigeriensis infected mice (Mus musculus) by oral dose',\n",
       " 'Compound was tested for antimalarial activity in mice (Mus musculus), infected with Plasmodium berghei N., activity is expressed as the mortality rate at a concentration of 10 mg/kg. in experiment 2; 5 out of 5',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 72 hrs by SYBR green 1 fluorescence-based method',\n",
       " 'Inhibition of 1-monooleoyl glycerol induced beta-hematin formation',\n",
       " 'Antiplasmodial activity as reduced parasitaemia against Plasmodium yoelii N67 infected Swiss mice (Mus musculus) at 10 mg/kg peroral dose',\n",
       " 'Antimalarial activity after 48 hrs against Plasmodium falciparum NF54 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Inhibitory concentration against Plasmodium falciparum D6 infected erythrocytes',\n",
       " 'Association constant with ferriprotoporphyrin IX.',\n",
       " 'Antimalarial activity as reduced parasitaemia after 72 hrs against chloroquine-resistant Plasmodium falciparum Dd2 in human erythrocytes by DAPI stain',\n",
       " 'Resistance index as ratio of IC50 for Plasmodium falciparum FcB1 and Thai strains',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 after 3 days by SYBR green I assay',\n",
       " 'Selectivity index, ratio of CC50 for human KB cells to IC50 for Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 gametocytes (stage 4 & 5)',\n",
       " 'In vitro growth inhibition against Plasmodium falciparum',\n",
       " 'Antimicrobial activity against Plasmodium falciparum harboring HFP-tagged Pfs16 protein after 48 hrs',\n",
       " 'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-resistant Plasmodium yoelii species. NS after subcutaneous administration',\n",
       " 'Antigametocyte activity against ring stage Plasmodium falciparum D10 assessed as inhibition of parasite growth at 50 nM after 1 to 8 hrs',\n",
       " 'Selective toxicity- EC50 value of FM3A / EC50 value of Plasmodium falciparum',\n",
       " 'Antimalarial activity against chloroquine,pyrimethamine-resistant Plasmodium falciparum K1 after 24 hrs',\n",
       " 'Antigametocyte activity against drug-resistant ring stage Plasmodium falciparum Dd2 schizonts assessed as inhibition of parasite growth at 50 nM after 1 to 8 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum W2 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum PA infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 as LDH activity after 48 hrs',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum 8425 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Inhibitory concentration against chloroquine-sensitive Plasmodium falciparum',\n",
       " 'Antimalarial activity against Plasmodium falciparum K1 infected in human erythrocytes after 72 hrs by lactate dehydrogenase assay',\n",
       " 'In vivo antimalarial activity in mice (Mus musculus) against chloroquine-sensitive Plasmodium berghei N after oral administration',\n",
       " 'Antimalarial activity against drug-resistant Plasmodium falciparum D6 infected in Aotus lemurinus lemurinus monkey',\n",
       " 'Inhibition of Plasmodium falciparum GP1',\n",
       " 'Antimalarial activity as reduced parasitaemia against Plasmodium berghei NK65 infected ICR mice (Mus musculus) at 30 mg/kg/day peroral dose at day 4',\n",
       " 'Antimalarial activity against Plasmodium falciparum W2mef trophozoite form by hoechst 33342-thiazole orange stain based flow cytometry assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum Pf3D70087/N9 infected in immunodeficient HM-IL2Rgamma null mouse assessed as decreased parasitemia at 50 mg/kg, po for 4 days after 28 days',\n",
       " 'In vivo antimalarial activity against Plasmodium yoelii in mice (Mus musculus) at 24 mg/kg/day orally on day 4 expressed as percent suppression',\n",
       " 'Antimalarial activity against Plasmodium falciparum PA assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antiplasmodial activity against drug resistant Plasmodium falciparum Dd2 ring stage cells assessed as reduction parasitemia by Malstat assay',\n",
       " 'In vitro inhibitory activity against chloroquine-sensitive Plasmodium falciparum African D6',\n",
       " 'Selectivity index, ratio of CC50 for african green monkey Vero C1008 cells to IC50 for Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against Plasmodium falciparum T9-96 infected Rhesus positive human erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum F32-Tanzania by [3H]hypoxanthine uptake',\n",
       " 'Anti-protozoal activity against Plasmodium falciparum K1 IEF stage after 72 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Selectivity ratio of IC50 for Plasmodium falciparum C235 to IC50 for Plasmodium falciparum D6',\n",
       " 'Antimalarial activity against Plasmodium falciparum C235 containing mdr1 transporter gene assessed as growth inhibition after 72 hrs by SYBR Green 1-based fluorescence assay',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey Vero cells to IC50 for chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as parasite growth inhibition after 72 hrs by MSF assay',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 by [3H]hypoxanthine incorporation',\n",
       " 'Growth inhibition of Plasmodium vivax isolate 4 assessed as parasite LDH synthesis after 48 hrs by double-site Plasmodium LDH antigen capture enzyme-linked immunosorbent assay',\n",
       " 'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 10 mg/kg/day after 4 days',\n",
       " 'Inhibitory concentration against chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 after 72 hrs by LDH assay',\n",
       " 'Resistant index. ratio of EC50 for chloroquine, mefloquine, pyrimethamine and atovaquone-resistant Plasmodium falciparum TM90-C2B to EC50 for chloroquine and pyrimethamine-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by fluorometric method',\n",
       " 'Number of Plasmodium berghei infected mice died on day 16 at 160 mg/kg',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       " 'Ratio of EC50 for rat L6 cells to EC50 for Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in African green monkey (Cercopithecus aethiops) Vero cells after 72 hrs by twofold serial dilution method',\n",
       " 'Inhibition of Plasmodium falciparum falcipain-2 after 12 hrs by fluorescence spectroscopy-based on-bead assay',\n",
       " 'Antimicrobial activity against fast-growing synchronous Plasmodium vivax by microscopy',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum D6 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antimicrobial activity against slow-growing synchronous Plasmodium vivax by microscopy',\n",
       " 'Growth inhibition of chloroquine-sensitive Plasmodium falciparum F32',\n",
       " 'Number of Plasmodium berghei infected mice died on day 25 at 640 mg/kg',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 by hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 by pLDH reporter assay',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA infected in Swiss mouse assessed as survival at 10 mg/kg, ip qd for 5 days coadministered with ritonavir 40 mg/kg, po',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA infected in NMRI mice (Mus musculus) assessed as reduction in parasitaemia at 10 mg/kg, perorally administered once daily for 3 days',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA infected Swiss mice (Mus musculus) assessed as reduction in parasitemia at 48 mg/kg, intraperitoneally after 3 days measured on day 4',\n",
       " 'Effective dose was determined in vivo for 90% parasite (Plasmodium berghei) reduction in the male albino mice after oral administration',\n",
       " 'Antimalarial activity against erythrocyte stages of chloroquine-resistant Plasmodium falciparum W2 infected in human erythrocytes by lactate dehydrogenase assay',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 after 48 hrs by FACS analysis in presence of 10 % human serum',\n",
       " 'Antimalarial activity against Plasmodium berghei infected in NMRI mice (Mus musculus) assessed as cure rat at 3 mg/kg, perorally administered for 3 days post infection measured after 30 days',\n",
       " 'Antimalarial activity after 48 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 by [3H]hypoxanthine uptake',\n",
       " 'Selectivity index, ratio of IC50 for human HepG2 cells to IC50 for chloroquine, pyrimethamine, and mefloquine-resistant Plasmodium falciparum Dd2',\n",
       " 'Antiplasmodial activity against chloroquine-susceptible Plasmodium falciparum K14 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine uptake after 48 hrs',\n",
       " 'Antiprotozoal activity after 48 hrs against chloroquine-resistant Plasmodium falciparum K1 infected erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against chloroquine-sensitive ring stage plasmodium falciparum 3D7 infected in erythrocytes assessed as [3H]hypoxanthine incorporation after 48 hrs by liquid scintillation counting',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 infected in human RBCs after 72 hrs by parasite lactate dehydrogenase assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum 3D7 infected in human O positive erythrocytes under low oxygen atmosphere after 72 hrs by spectrophotometric analysis',\n",
       " 'Compound was evaluated for uM concentration.',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ANKA infected in ip dosed Swiss albino mouse assessed as suppression of parasitemia measured on day 4 post infection by Giemsa staining',\n",
       " 'Resistant index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum W2 to IC50 for chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Selectivity index, ratio of CC50 for african green monkey Vero C1008 cells to IC50 for Plasmodium falciparum 3D7',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum Ghana in human erythrocytes after 72 hrs by Malstat assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum HB3 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity as reduced schizont maturation in Plasmodium berghei ANKA infected mice (Mus musculus) at 5 mg/kg/day peroral dose over 4 days',\n",
       " 'Resistance index as IC50 for Plasmodium falciparum K1 and Thai strains',\n",
       " 'Antiparasitic activity against chloroquine-resistant Plasmodium falciparum K1',\n",
       " 'Antimalarial activity against Plasmodium falciparum Nigerian assessed as [3H]hypoxanthine uptake after 48 hrs by liquid scintillation counting',\n",
       " 'Antiplasmodial activity against Plasmodium berghei NK65 infected in Swiss Webster mice (Mus musculus) assessed as average parasitaemia at 200 mg/kg, perorally administered 1 day after infection measured after 10 days post infection',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D6 after 72 hrs by SYBR green 1 fluorescence-based method',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 72 hrs by DAPI staining method',\n",
       " 'Antimalarial efficacy against Plasmodium berghei in mice (Mus musculus) when administered subcutaneously each day for 4 days to five mice (Mus musculus) per dose regimen',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 infected in human red blood cells after 72 hrs by parasite lactate dehydrogenase assay',\n",
       " 'Antimalarial activity in mice (Mus musculus), infected with Plasmodium berghei N. activity is expressed as the percent of parasitaemia observed in mice (Mus musculus) at end of 4-day test at a concentration of 1 mg/kg in experiment 2',\n",
       " 'Parasitaemia (%) in tail blood smears of Plasmodium berghei infected ICR mice (Mus musculus) at 20 mg/kg/day after 4 days',\n",
       " 'Selectivity ratio of IC50 for human HepG2 cells to IC50 for chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Number of Plasmodium berghei infected mice died on day 18 at 160 mg/kg',\n",
       " 'Antiplasmodial activity against artemisinin-tolerant Plasmodium falciparum F32-Tanzania assessed as time required to reach 5% parasitaemia at 0.2 uM treated for 48 hrs',\n",
       " 'Inhibition of Plasmodium falciparum K1 as [3H]hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 by [3H]hypoxanthine incorporation assay',\n",
       " 'Antiplasmodial potency relative to chloroquine',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA expressing GFP infected in Sprague-Dawley rat assessed as reduction in parasitemia at 30 mg/kg, po administered as 4 doses measured on day 4 post-infection by flow cytometry',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum HB3 by [3H]hypoxanthine uptake',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum NF54 infected in human erythrocytes assessed as decrease in parasitemia measured on day 3 post-treatment by geimsa staining (Rvb = 2.18 +/- 0.17%)',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum D6 by Malstat LDH activity',\n",
       " 'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 (CDC/Sierra Leone I)',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum FcB1 after 24 hrs',\n",
       " 'Inhibitory activity against Plasmodium falciparum W2',\n",
       " 'Selectivity index, ratio of IC50 for african green monkey (Cercopithecus aethiops) Vero cells to IC50 for chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'In vivo antimalarial activity against Plasmodium berghei N on subcutaneous administration.',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 ring-stage infected in human erythrocytes after 48 hrs by [3H]hypoxanthine assay',\n",
       " 'Growth inhibition of chloroquine-resistant Plasmodium falciparum KI',\n",
       " 'Antimalarial activity against Plasmodium vinckei petteri infected in CD mice (Mus musculus) assessed as inhibition of parasitaemia dosed daily for 4 days measured on day 5',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum Thai after 24 hrs by semiautomated micro dilution assay',\n",
       " 'In vitro antimalarial activity against Plasmodium falciparum FcB1',\n",
       " 'Antimalarial activity against Plasmodium falciparum assessed as parasite growth inhibition after 48 hrs by [3H]hypoxanthin incorporation assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum IMT Vol assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity against Plasmodium falciparum IMT 16332 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity against wild type early trophozoite stage of Plasmodium falciparum D6 in human red blood cells assessed as [3H]hypoxanthine uptake after 96 hrs',\n",
       " 'Effect on survival of CD1 mice (Mus musculus) infected with Plasmodium berghei KBG173 at 4 mg/kg/day, peroral',\n",
       " 'Effective in vivo dose ED90 against Plasmodium berghei N on subcutaneous administration',\n",
       " 'Antimalarial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as mean survival time at 30 mg/kg, po administered as quadruple dose regimen',\n",
       " 'Antimalarial activity after 24 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected type A+ human erythrocytes by [3H]hypoxanthine uptake',\n",
       " 'In vivo antimalarial activity against Plasmodium yoelii in Swiss mice (Mus musculus) on day 4 at the dose of 48 mg/kg/day orally',\n",
       " 'Antiplasmodial activity against Plasmodium berghei NK65 infected in Swiss Webster mice (Mus musculus) assessed as average parasitaemia at 200 mg/kg, perorally administered 1 day after infection measured after 7 days post infection',\n",
       " 'Antiprotozoal activity against Plasmodium falciparum',\n",
       " 'Selectivity index, ratio of IC50 for human KB cells to IC50 for chloroquine-resistant Plasmodium falciparum FCR3/Gambia',\n",
       " 'Survival rate in Plasmodium berghei NK65 infected JCL-ICR mice (Mus musculus) at 50 mg/kg body weight after 14 days',\n",
       " 'Antimalarial activity against Plasmodium falciparum FCM29 assessed as inhibition of [3H] incorporation after 48 hrs by scintillation counter',\n",
       " 'Antimalarial activity against Plasmodium falciparum K1 assessed as parasite growth inhibition after 72 hrs by MSF assay',\n",
       " 'Antimalarial activity against chloroquine sensitive Plasmodium falciparum FCR-3',\n",
       " 'Antimalarial activity against chloroquine resistant, mefloquine sensitive Plasmodium falciparum W2 infected in human erythrocytes by [3H]-hypoxanthine incorporation assay',\n",
       " 'In vitro efficacy for chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against mefloquine-resistant, chloroquine-sensitive Plasmodium falciparum D6 assessed as inhibition of [3H]hypoxanthine uptake',\n",
       " 'Antimalarial activity against drug-resistant Plasmodium falciparum TM91C235',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum 3D7 infected in erythrocytes after 72 hrs by syber green 1 assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes after 48 hrs by SYBR green 1-based fluorescence assay',\n",
       " 'Antiplasmodial activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1 assessed as inhibition of [3H]hypoxanthine incorporation incubated for 48 hrs prior to [3H] hypoxanthine addition measured after 24 hrs by liquid scintillation counting',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in RBC assessed as plasmodial LDH activity after 72 hrs',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum D6 infected in African green monkey (Cercopithecus aethiops) Vero cells assessed as parasite LDH activity after 72 hrs',\n",
       " 'Antimalarial activity against multidrug-resistant Plasmodium falciparum W2',\n",
       " 'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum K1Hf in presence of 5 uM verapamil by [3H]hypoxanthine incorporation assay',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocytes assessed as inhibition of [3H]hypoxanthine incorporation after 48 hrs by beta liquid scintillation counting method',\n",
       " 'Antiparasitic activity against chloroquine-sensitive Plasmodium falciparum K1AM pretreated with 0.1 uM phenobarbitone for 48 hrs by [3H]hypoxanthine incorporation assay',\n",
       " 'Inhibition of Plasmodium falciparum in HRP2 ELISA',\n",
       " 'Antimalarial activity in Plasmodium berghei ANKA 65 infected Swiss CD1 mice (Mus musculus) as reduced parasitaemia at 10 mg/kg initial oral dose and further intraperitoneal dose after 4 days',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium yoelii N67 infected in Swiss mice (Mus musculus) assessed as inhibition of parasitaemia at 10 mg/kg, perorally administered for 4 days measured on day 4 post-infection',\n",
       " 'Ability to associate with ferriprotoporphyrin IX',\n",
       " 'Antimalarial activity against drug-sensitive Plasmodium falciparum 3D7 after 24 hrs',\n",
       " 'Antimalarial activity against chloroquine-resistant Plasmodium falciparum W2 infected in type A rhesus-positive human erythrocytes assessed as [3H]hypoxanthine incorporation after 48 hrs by scintillation counting',\n",
       " 'In vitro antimalarial activity against chloroquine-sensitive Plasmodium falciparum K1',\n",
       " 'Resistance index, ratio IC50 for chloroquine-resistant Plasmodium falciparum Dd2 to IC50 for chloroquine-sensitive Plasmodium falciparum HB3',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium falciparum HB3 after 72 hrs',\n",
       " 'Selectivity index, ratio of CC50 for human MRC5 cells to IC50 for Plasmodium falciparum K1',\n",
       " 'Antiprotozoal activity against chloroquine and pyrimethamine-resistant Plasmodium falciparum K1',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum HB3 assessed as SYBR Green 1 fluorescence emission after 72 hrs',\n",
       " 'Selectivity index, ratio of IC50 for human KB cells to IC50 for chloroquine-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ANKA infected BALB/c mice (Mus musculus) erythrocytes at 10 uM after 18 hrs as reduced hemoglobin hydrolysis',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum D10 after 72 hrs by parasite lactate dehydrogenase assay',\n",
       " 'The compound was tested for survival of the ICR mice (infected with Plasmodium berghei) as a symptom indicative of toxicity on day 4, at a dose of 20 mg/kg/day',\n",
       " 'Antimicrobial activity against Plasmodium falciparum harboring CVMNT genotype after 72 hrs by SYBR green I assay',\n",
       " 'Inhibition of Plasmodium falciparum falcipain 3 using substrate benzoxycarbonyl-Leu-Arg-7-amino-4-methyl-coumarin preincubated for 30 mins before substrate addition by fluorescence assay',\n",
       " 'Antimalarial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction in parasitemia at 30 mg/kg, po administered as single dose after 72 hrs by flow cytometry',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 after 72 hrs by SYBR green 1 assay',\n",
       " 'Growth inhibition of chloroquine-sensitive Plasmodium falciparum D10',\n",
       " 'Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as inhibition of ring stage parasite growth at IC50 after 6 hr by [3H]hypoxanthine incorporation assay',\n",
       " 'Growth inhibitory concentration against Plasmodium falciparum NF54',\n",
       " 'Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum FcB1 to IC50 for drug-sensitive Plasmodium falciparum 3D7',\n",
       " 'Antimalarial activity against chloroquine-sensitive Plasmodium berghei ATCC 50175 infected in ICR mouse assessed as chemosuppression of parasitemia at 5 mg/kg/day, po pretreated for 4 days before infection and measured after 72 hrs',\n",
       " 'Selectivity index, ratio of CC50 for human KB cells to IC50 for Plasmodium falciparum VS1',\n",
       " 'Resistance index, ratio of IC50 for chloroquine-resistant Plasmodium falciparum PFB to IC50 for chloroquine-sensitive Plasmodium falciparum FC32',\n",
       " 'Inhibition of hydrogen peroxide-mediated haem detoxification in Plasmodium falciparum',\n",
       " 'Antiplasmodial activity against Plasmodium falciparum 3D7 assessed as reduction in parasitemia measured between day 1 and day 2 relative to control',\n",
       " 'Antimalarial activity against GFP-tagged Plasmodium berghei ANKA infected in NMRI mouse assessed as mouse survival at 30 mg/kg, po QD administered 24 hrs post infection for 3 days measured on day 30 post infection',\n",
       " 'Antimalarial activity against GFP-transfected Plasmodium berghei ANKA infected in po dosed NMRI mouse assessed as reduction in parasitemia administered as single dose after 72 hrs by flow cytometry',\n",
       " 'Antimalarial activity against GFP-transfected Plasmodium berghei ANKA infected in NMRI mouse assessed as reduction in parasitemia at 10 mg/kg, po administered as single dose after 72 hrs by flow cytometry',\n",
       " 'Reversal of chloroquine-resistance in Plasmodium chabaudi infected in mouse at 10 mg/kg, po coadministered with chloroquine 3 mg/kg, iv administered for 3 consecutive days measured on day 4',\n",
       " 'Ratio of cytotoxicity against rat L6 cells to IC50 for chloroquine-resistant Plasmodium falciparum NF54',\n",
       " 'Antiplasmodial activity as reduced parasitaemia against chloroquine-resistant Plasmodium yoelii N67 infected Swiss mice (Mus musculus) at 10 mg/kg/day peroral dose after 4 days',\n",
       " 'Antimalarial activity as schizonticidal activity after 48 hrs against chloroquine-sensitive Plasmodium falciparum 3D7',\n",
       " 'Inhibition of Plasmodium falciparum 3D7',\n",
       " 'Antigametocyte activity against Plasmodium falciparum D10 trophozoites assessed as inhibition of parasite growth at 50 nM after 1 to 8 hrs',\n",
       " 'Antimalarial activity after 72 hrs against chloroquine-sensitive Plasmodium falciparum 3D7 infected erythrocytes by MSF assay',\n",
       " 'Percent parasitemia after 0.75 mg/kg dose',\n",
       " 'Antimalarial activity against Plasmodium berghei infected ICR mice (Mus musculus) daily intraperitoneal dose for 4 days by Thompson test',\n",
       " 'Antimalarial activity against transgenic Plasmodium falciparum 3D7 infected in human A positive erythrocytes after 72 hrs by luciferase reporter gene assay',\n",
       " 'Antimalarial activity in mice (Mus musculus), infected with Plasmodium berghei N. activity is expressed as the percent of parasitaemia observed in mice (Mus musculus) at end of 4-day test at a concentration of 10 mg/kg in experiment 1',\n",
       " 'Antimalarial activity against Plasmodium vivax with >50% parasites at ring stage infected in human erythrocytes assessed as growth inhibition after 30 to 50 hrs by microscopic analysis using giemsa staining',\n",
       " 'Antimalarial activity against chloroquine-resistant and mefloquine-sensitive Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against Plasmodium knowlesi infected in rhesus monkey RBC assessed as [3H]-hypoxanthine incorporation after 12 hrs by scintillation counting',\n",
       " 'Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2 by [3H]hypoxanthine uptake',\n",
       " 'Selectivity index, ratio of ED50 for human KB cells to IC50 for chloroquine-sensitive Plasmodium falciparum D6',\n",
       " 'Antimalarial activity against Plasmodium berghei infected in NMRI mice (Mus musculus) assessed as survival time at 3 mg/kg, perorally administered for 3 days post infection',\n",
       " 'Antimalarial activity against chloroquine, pyrimethamine, and mefloquine-resistant Plasmodium falciparum Dd2 infected in human O positive red blood cells assessed as inhibition of [3H]-hypoxanthine uptake after 48 hrs',\n",
       " 'In vivo effective dose for antimalarial activity by intraperitoneal dose',\n",
       " 'Antiplasmodial activity against multidrug-resistant Plasmodium falciparum K1 ring stage after 72 hrs by SYBP Green fluorescence-based assay',\n",
       " 'Antimalarial activity against Plasmodium falciparum FAC8',\n",
       " 'Antiplasmodial activity against chloroquinone-resistant Plasmodium falciparum W2',\n",
       " 'Antimalarial activity against Plasmodium berghei str. ANKA infected in NMRI mouse assessed as mean survival days at 10 mg/kg, po qd for 4 days (Rvb = 7 days)',\n",
       " 'Antimalarial activity against Plasmodium berghei ANKA expressing GFP infected in Sprague-Dawley rat assessed as reduction in parasitemia at 3 mg/kg, po administered as single dose measured on day 3 post-infection by flow cytometry',\n",
       " 'Antiplasmodial activity after 24 hrs against chloroquine-sensitive Plasmodium falciparum D6 infected human erythrocytes by [3H]hypoxanthine uptake',\n",
       " ...]"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(new_df.ASSAY_DESCRIPTION.unique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['nM',\n",
       " nan,\n",
       " '%',\n",
       " 'ug.mL-1',\n",
       " 'ng/ml',\n",
       " 'days',\n",
       " 'mg kg-1 day-1',\n",
       " 'um',\n",
       " 'mg Kg-1',\n",
       " 'mg kg-1',\n",
       " 'day',\n",
       " 'mg.kg-1',\n",
       " 'ug ml-1',\n",
       " 'nM hr',\n",
       " 'mg kg-1 day-1 x 5',\n",
       " 'mg/kg/day',\n",
       " 'mg ml-1',\n",
       " 'uM kg-1',\n",
       " 'ng ml-1',\n",
       " 'umol.kg-1',\n",
       " 'mL.min-1.kg-1',\n",
       " \"10'-8mol\",\n",
       " 'milliequivalent',\n",
       " 'uM',\n",
       " 'L.kg-1',\n",
       " 'molar ratio',\n",
       " 'hr',\n",
       " 'ug well-1',\n",
       " 'uM well-1',\n",
       " 'Cures/total',\n",
       " 'min-1',\n",
       " 's-1',\n",
       " 'M-1 s-1',\n",
       " 'ng.hr/ml',\n",
       " 'hr.ng/ml',\n",
       " 'mg kg-1 day-1 x 4',\n",
       " 'MST',\n",
       " 'nM g-1',\n",
       " 'ml/min',\n",
       " 'l',\n",
       " 'ng hr ml-1',\n",
       " 'uM ml-1',\n",
       " 'pM mg-1',\n",
       " 'nM hr-1 mg-1',\n",
       " 'mU mg-1',\n",
       " 'nM mg-1',\n",
       " 'mg mg-1',\n",
       " 'hr-1',\n",
       " \"10'6/M\",\n",
       " \"10'7/M\",\n",
       " 'mmHg',\n",
       " 'uM hr',\n",
       " 'min',\n",
       " 'uL min-1 mg-1',\n",
       " \"10'5/M\",\n",
       " 'ug',\n",
       " 'M-1 min-1',\n",
       " 'uM.min',\n",
       " 'cpm/uL',\n",
       " 'mL.min-1.g-1',\n",
       " 'nm/s',\n",
       " '10-6 cm/s',\n",
       " '%,%',\n",
       " 'g']"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list(new_df.STANDARD_UNITS.unique())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "np.int64(266106)"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.MOLREGNO.duplicated().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "MOLREGNO\n",
       "23         13440.525000\n",
       "111        11200.200000\n",
       "120                 NaN\n",
       "146        11214.775000\n",
       "147          165.100000\n",
       "               ...     \n",
       "1531021      315.522775\n",
       "1531022      108.542300\n",
       "1531023       90.761275\n",
       "1531024       44.429225\n",
       "1540450       68.919600\n",
       "Name: STANDARD_VALUE, Length: 266307, dtype: float64"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "new_df[\"STANDARD_VALUE\"].aggregate(\"mean\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0         nM\n",
       "1         nM\n",
       "2         nM\n",
       "3         nM\n",
       "4         nM\n",
       "          ..\n",
       "532388     %\n",
       "532389    nM\n",
       "532390     %\n",
       "532391    nM\n",
       "532392    nM\n",
       "Name: STANDARD_UNITS, Length: 479672, dtype: object"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "su = new_df['STANDARD_UNITS']\n",
    "\n",
    "su.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<pandas.core.groupby.generic.SeriesGroupBy object at 0x7f90e54effd0>"
      ]
     },
     "execution_count": 55,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df[\"MOLREGNO\", ]\"MOLREGNO\")[\"STANDARD_VALUE\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "MOLREGNO\n",
       "23         13440.525000\n",
       "111        11200.200000\n",
       "120                 NaN\n",
       "146        11214.775000\n",
       "147          165.100000\n",
       "               ...     \n",
       "1531021      315.522775\n",
       "1531022      108.542300\n",
       "1531023       90.761275\n",
       "1531024       44.429225\n",
       "1540450       68.919600\n",
       "Name: STANDARD_VALUE, Length: 266307, dtype: float64"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "avg_standard_value"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/mr/bl2q5rxs0t3d8d8tn7wdcxz80000gp/T/ipykernel_96627/1629321367.py:1: FutureWarning: The provided callable <built-in function sum> is currently using SeriesGroupBy.sum. In a future version of pandas, the provided callable will be used directly. To keep current behavior pass the string \"sum\" instead.\n",
      "  new_df[\"Agg Standard Val\"] = new_df[\"STANDARD_VALUE\"].aggregate(sum)\n"
     ]
    },
    {
     "ename": "TypeError",
     "evalue": "'DataFrameGroupBy' object does not support item assignment",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[36], line 1\u001b[0m\n\u001b[0;32m----> 1\u001b[0m \u001b[43mnew_df\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mAgg Standard Val\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m]\u001b[49m \u001b[38;5;241m=\u001b[39m new_df[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mSTANDARD_VALUE\u001b[39m\u001b[38;5;124m\"\u001b[39m]\u001b[38;5;241m.\u001b[39maggregate(\u001b[38;5;28msum\u001b[39m)\n",
      "\u001b[0;31mTypeError\u001b[0m: 'DataFrameGroupBy' object does not support item assignment"
     ]
    }
   ],
   "source": [
    "new_df[\"Agg Standard Val\"] = new_df[\"STANDARD_VALUE\"].aggregate(mean)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "malaria",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.10"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
